false--12-31Q120200001707092000.010.011200000000120000000086071640862817130.010.01500000005000000000 0001707092 2020-01-01 2020-03-31 0001707092 2019-01-01 2019-03-31 0001707092 2020-05-01 0001707092 2019-12-31 0001707092 2020-03-31 0001707092 2018-12-31 0001707092 2019-03-31 0001707092 us-gaap:CommonStockMember 2020-03-31 0001707092 us-gaap:RetainedEarningsMember 2019-12-31 0001707092 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001707092 us-gaap:CommonStockMember 2019-12-31 0001707092 us-gaap:NoncontrollingInterestMember 2019-12-31 0001707092 dlph:TotalDelphiTechnologiesShareholdersEquityMember 2020-01-01 2020-03-31 0001707092 us-gaap:NoncontrollingInterestMember 2020-03-31 0001707092 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001707092 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001707092 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001707092 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001707092 dlph:TotalDelphiTechnologiesShareholdersEquityMember 2020-03-31 0001707092 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001707092 dlph:TotalDelphiTechnologiesShareholdersEquityMember 2019-12-31 0001707092 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001707092 us-gaap:RetainedEarningsMember 2020-03-31 0001707092 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001707092 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001707092 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001707092 us-gaap:NoncontrollingInterestMember 2018-12-31 0001707092 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001707092 us-gaap:RetainedEarningsMember 2019-03-31 0001707092 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0001707092 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001707092 dlph:TotalDelphiTechnologiesShareholdersEquityMember 2019-03-31 0001707092 us-gaap:RetainedEarningsMember 2018-12-31 0001707092 us-gaap:CommonStockMember 2018-12-31 0001707092 dlph:TotalDelphiTechnologiesShareholdersEquityMember 2019-01-01 2019-03-31 0001707092 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001707092 dlph:TotalDelphiTechnologiesShareholdersEquityMember 2018-12-31 0001707092 us-gaap:NoncontrollingInterestMember 2019-03-31 0001707092 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001707092 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001707092 us-gaap:CommonStockMember 2019-03-31 0001707092 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001707092 2017-12-04 2017-12-04 0001707092 dlph:TulaMember 2020-03-31 0001707092 dlph:PolyChargeMember 2020-03-31 0001707092 dlph:PolyChargeMember 2019-12-31 0001707092 dlph:TulaMember 2019-12-31 0001707092 srt:MaximumMember 2020-01-01 2020-03-31 0001707092 us-gaap:EmployeeSeveranceMember 2020-01-01 2020-03-31 0001707092 us-gaap:OtherRestructuringMember 2020-03-31 0001707092 us-gaap:EmployeeSeveranceMember 2020-03-31 0001707092 us-gaap:OtherRestructuringMember 2019-12-31 0001707092 us-gaap:OtherRestructuringMember 2020-01-01 2020-03-31 0001707092 us-gaap:EmployeeSeveranceMember 2019-12-31 0001707092 dlph:DelphiTechnologiesAftermarketSegmentMember 2019-01-01 2019-12-31 0001707092 dlph:DelphiTechnologiesPTPSegmentMember 2019-01-01 2019-12-31 0001707092 dlph:DelphiTechnologiesAftermarketSegmentMember 2020-01-01 2020-03-31 0001707092 2019-01-01 2019-12-31 0001707092 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0001707092 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0001707092 dlph:DelphiTechnologiesPTPSegmentMember 2020-01-01 2020-03-31 0001707092 dlph:DelphiTechnologiesFISSegmentMember 2019-01-01 2019-12-31 0001707092 dlph:DelphiTechnologiesFISSegmentMember 2020-01-01 2020-03-31 0001707092 dlph:DelphiTechnologiesEESegmentMember 2019-01-01 2019-12-31 0001707092 dlph:DelphiTechnologiesEESegmentMember 2020-01-01 2020-03-31 0001707092 us-gaap:RevolvingCreditFacilityMember 2020-03-31 0001707092 dlph:CapitalLeasesandOtherDebtMember 2020-03-31 0001707092 dlph:TermLoanAFacilityMember us-gaap:LineOfCreditMember 2020-03-31 0001707092 dlph:CapitalLeasesandOtherDebtMember 2019-12-31 0001707092 dlph:TermLoanAFacilityMember us-gaap:LineOfCreditMember 2019-12-31 0001707092 us-gaap:SeniorNotesMember 2020-03-31 0001707092 us-gaap:SeniorNotesMember 2019-12-31 0001707092 us-gaap:RevolvingCreditFacilityMember dlph:SeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001707092 us-gaap:RevolvingCreditFacilityMember dlph:TermLoanAFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-03-31 0001707092 us-gaap:RevolvingCreditFacilityMember dlph:TermLoanAFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001707092 us-gaap:RevolvingCreditFacilityMember dlph:SeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember dlph:AlternativeBaseRateMember 2019-01-01 2019-03-31 0001707092 us-gaap:RevolvingCreditFacilityMember dlph:SeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember dlph:AlternativeBaseRateMember 2020-01-01 2020-03-31 0001707092 us-gaap:RevolvingCreditFacilityMember dlph:SeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-03-31 0001707092 us-gaap:RevolvingCreditFacilityMember dlph:TermLoanAFacilityMember us-gaap:LineOfCreditMember dlph:AlternativeBaseRateMember 2019-01-01 2019-03-31 0001707092 us-gaap:RevolvingCreditFacilityMember dlph:TermLoanAFacilityMember us-gaap:LineOfCreditMember dlph:AlternativeBaseRateMember 2020-01-01 2020-03-31 0001707092 dlph:DelphiTechnologiesAftermarketSegmentMember 2019-01-01 2019-03-31 0001707092 srt:EuropeMember 2019-01-01 2019-03-31 0001707092 dlph:SeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2017-09-07 0001707092 dlph:SeniorUnsecuredNotesDue2025Member us-gaap:SeniorNotesMember 2017-09-28 0001707092 us-gaap:RevolvingCreditFacilityMember dlph:SeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2017-09-07 0001707092 dlph:TermLoanAFacilityMember dlph:SeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2017-09-07 0001707092 us-gaap:ForeignPlanMember 2019-01-01 2019-03-31 0001707092 us-gaap:ForeignPlanMember 2020-01-01 2020-03-31 0001707092 dlph:OrdinaryBusinessLitigationMember srt:MaximumMember us-gaap:PendingLitigationMember 2020-03-31 0001707092 dlph:ElectrificationElectronicsMember 2020-01-01 2020-03-31 0001707092 dlph:DelphiTechnologiesFISSegmentMember 2020-01-01 2020-03-31 0001707092 dlph:OriginalEquipmentServiceMember 2019-01-01 2019-03-31 0001707092 dlph:PowertrainSystemsSegmentMember 2019-01-01 2019-03-31 0001707092 dlph:DelphiTechnologiesFISSegmentMember 2019-01-01 2019-03-31 0001707092 dlph:PowertrainSystemsSegmentMember 2020-01-01 2020-03-31 0001707092 dlph:IndependentAftermarketMember 2019-01-01 2019-03-31 0001707092 dlph:DelphiTechnologiesPTPSegmentMember 2020-01-01 2020-03-31 0001707092 dlph:IndependentAftermarketMember 2020-01-01 2020-03-31 0001707092 dlph:OriginalEquipmentServiceMember 2020-01-01 2020-03-31 0001707092 dlph:DelphiTechnologiesPTPSegmentMember 2019-01-01 2019-03-31 0001707092 dlph:ElectrificationElectronicsMember 2019-01-01 2019-03-31 0001707092 srt:SouthAmericaMember 2019-01-01 2019-03-31 0001707092 srt:AsiaPacificMember 2020-01-01 2020-03-31 0001707092 srt:NorthAmericaMember 2019-01-01 2019-03-31 0001707092 srt:EuropeMember 2020-01-01 2020-03-31 0001707092 srt:SouthAmericaMember 2020-01-01 2020-03-31 0001707092 srt:AsiaPacificMember 2019-01-01 2019-03-31 0001707092 srt:NorthAmericaMember 2020-01-01 2020-03-31 0001707092 dlph:SharerepurchaseProgramJanuary2019Domain 2020-03-31 0001707092 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0001707092 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0001707092 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001707092 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001707092 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0001707092 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0001707092 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0001707092 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-03-31 0001707092 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0001707092 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0001707092 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0001707092 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0001707092 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0001707092 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-03-31 0001707092 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-03-31 0001707092 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0001707092 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001707092 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001707092 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0001707092 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001707092 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0001707092 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0001707092 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2020-01-01 2020-03-31 0001707092 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-01-01 2020-03-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001707092 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001707092 us-gaap:NondesignatedMember 2019-01-01 2019-03-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-01-01 2019-03-31 0001707092 us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0001707092 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2019-01-01 2019-03-31 0001707092 us-gaap:NondesignatedMember 2020-01-01 2020-03-31 0001707092 srt:ScenarioForecastMember us-gaap:CostOfSalesMember 2019-10-01 2020-09-30 0001707092 us-gaap:CurrencySwapMember 2020-03-31 0001707092 srt:ScenarioForecastMember us-gaap:CostOfSalesMember 2020-10-01 2021-09-30 0001707092 us-gaap:InterestRateSwapMember 2018-12-31 0001707092 currency:CNY us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0001707092 currency:PLN us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0001707092 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0001707092 currency:SGD us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0001707092 currency:GBP us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0001707092 currency:MXN us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0001707092 currency:TRY us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0001707092 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0001707092 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0001707092 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001707092 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001707092 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001707092 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0001707092 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001707092 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0001707092 us-gaap:NondesignatedMember 2020-03-31 0001707092 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001707092 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001707092 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001707092 us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001707092 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001707092 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001707092 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001707092 us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001707092 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001707092 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001707092 us-gaap:NondesignatedMember 2019-12-31 0001707092 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001707092 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001707092 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001707092 us-gaap:FairValueInputsLevel2Member 2020-03-31 0001707092 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0001707092 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0001707092 us-gaap:FairValueInputsLevel2Member 2019-12-31 0001707092 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001707092 us-gaap:RestrictedStockUnitsRSUMember 2020-03-31 0001707092 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0001707092 srt:MaximumMember dlph:ExecutiveMember us-gaap:RestrictedStockUnitsRSUMember dlph:DelphiTechnologiesPLCLongTermIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-01-01 2018-12-31 0001707092 dlph:EmployeeandNonemployeemembersMember us-gaap:RestrictedStockUnitsRSUMember 2018-04-25 2018-04-25 0001707092 dlph:EmployeeandNonemployeemembersMember us-gaap:RestrictedStockUnitsRSUMember 2018-04-26 2018-04-26 0001707092 dlph:EmployeeandNonemployeemembersMember us-gaap:RestrictedStockUnitsRSUMember 2019-04-25 2019-04-25 0001707092 dlph:EmployeeandNonemployeemembersMember us-gaap:RestrictedStockUnitsRSUMember 2019-04-24 2019-04-24 0001707092 dlph:EmployeeandNonemployeemembersMember us-gaap:RestrictedStockUnitsRSUMember 2020-04-23 2020-04-23 0001707092 dlph:EmployeeandNonemployeemembersMember us-gaap:RestrictedStockUnitsRSUMember 2020-04-22 2020-04-22 0001707092 dlph:EmployeeandNonemployeemembersMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0001707092 us-gaap:RestrictedStockUnitsRSUMember dlph:PlcLongTermIncentivePlanMember 2018-01-01 2018-09-30 0001707092 srt:ManagementMember dlph:A2020GrantDomain us-gaap:RestrictedStockUnitsRSUMember dlph:PlcLongTermIncentivePlanMember 2020-01-01 2020-03-31 0001707092 srt:ManagementMember dlph:A2019GrantMemberMember us-gaap:RestrictedStockUnitsRSUMember dlph:PlcLongTermIncentivePlanMember 2019-01-01 2019-03-31 0001707092 srt:ManagementMember dlph:A2018GrantMember us-gaap:RestrictedStockUnitsRSUMember dlph:PlcLongTermIncentivePlanMember 2018-01-01 2018-09-30 0001707092 us-gaap:RestrictedStockUnitsRSUMember dlph:PlcLongTermIncentivePlanMember 2019-01-01 2019-03-31 0001707092 us-gaap:RestrictedStockUnitsRSUMember dlph:PlcLongTermIncentivePlanMember 2020-01-01 2020-03-31 0001707092 us-gaap:OperatingSegmentsMember dlph:DelphiTechnologiesPTPSegmentMember 2019-01-01 2019-03-31 0001707092 us-gaap:OperatingSegmentsMember dlph:DelphiTechnologiesAftermarketSegmentMember 2019-01-01 2019-03-31 0001707092 us-gaap:OperatingSegmentsMember dlph:DelphiTechnologiesFISSegmentMember 2019-01-01 2019-03-31 0001707092 us-gaap:OperatingSegmentsMember dlph:DelphiTechnologiesEESegmentMember 2019-01-01 2019-03-31 0001707092 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-03-31 0001707092 us-gaap:OperatingSegmentsMember dlph:DelphiTechnologiesAftermarketSegmentMember 2020-01-01 2020-03-31 0001707092 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0001707092 us-gaap:OperatingSegmentsMember dlph:DelphiTechnologiesEESegmentMember 2020-01-01 2020-03-31 0001707092 us-gaap:OperatingSegmentsMember dlph:DelphiTechnologiesFISSegmentMember 2020-01-01 2020-03-31 0001707092 us-gaap:OperatingSegmentsMember dlph:DelphiTechnologiesPTPSegmentMember 2020-01-01 2020-03-31 xbrli:pure iso4217:TRY iso4217:CNY iso4217:EUR iso4217:SGD xbrli:shares iso4217:MXN iso4217:USD xbrli:shares iso4217:GBP iso4217:USD
Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________________________________________________________________
FORM 10-Q
___________________________________________________________________________________________________
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             .
Commission file number: 001-38110
____________________________________________________________________________________________
DELPHI TECHNOLOGIES PLC
(Exact name of registrant as specified in its charter)
____________________________________________________________________________________________
Jersey
 
98-1367514
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
 Identification No.)
One Angel Court
10th Floor
London, EC2R 7HJ
United Kingdom
(Address of principal executive offices)
011-44-020-305-74300
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
____________________________________________________________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Ordinary shares. $0.01 par value per share
DLPH
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  .    No .
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  .    No  .
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
  
 
 
Accelerated filer
Non-accelerated filer
 
  
 
 
Smaller reporting company
 
 
 
 
 
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. .
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes  .  No  .
The number of the registrant’s ordinary shares outstanding as of May 1, 2020, was 86,349,731.


Table of Contents


DELPHI TECHNOLOGIES PLC
INDEX 

 
 
Page
Part I - Financial Information
Item 1.
 
 
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
 
 
 
Part II - Other Information
Item 1.
Item 1A.
Item 6.
 
 
 
 

2

Table of Contents


PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS
DELPHI TECHNOLOGIES PLC
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
Three Months Ended March 31,
 
2020
 
2019
 
 
 
 
 
(in millions, except per share amounts)
Net sales
$
945

 
$
1,151

Operating expenses:
 
 
 
Cost of sales
824

 
983

Selling, general and administrative
95

 
104

Amortization
3

 
6

Restructuring (Note 7)
43

 
3

Total operating expenses
965

 
1,096

Operating (loss) income
(20
)
 
55

Interest expense
(16
)
 
(18
)
Other income (expense), net (Note 17)
2

 
(12
)
(Loss) income before income taxes and equity income
(34
)
 
25

Income tax expense
(20
)
 
(8
)
(Loss) income before equity income
(54
)
 
17

Equity income, net of tax

 
2

Net (loss) income
(54
)
 
19

Net income attributable to noncontrolling interest
3

 
3

Net (loss) income attributable to Delphi Technologies
$
(57
)
 
$
16

 
 
 
 
Net income per share attributable to Delphi Technologies:
 
 
 
Basic
$
(0.66
)
 
$
0.18

Diluted
$
(0.66
)
 
$
0.18

 
 
 
 
Weighted average ordinary shares outstanding:
 
 
 
Basic
86.17

 
88.45

Diluted
86.28

 
88.55

See notes to consolidated financial statements.

3

Table of Contents


DELPHI TECHNOLOGIES PLC
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
 
Three Months Ended March 31,
 
2020
 
2019
 
 
 
 
 
(in millions)
Net (loss) income
$
(54
)
 
$
19

Other comprehensive (loss) income:
 
 
 
Currency translation adjustments
(46
)
 
9

Net change in unrecognized gain on derivative instruments, net of tax (Note 15)
4

 
16

Employee benefit plans adjustment, net of tax
13

 
34

Other comprehensive (loss) income
(29
)
 
59

Comprehensive (loss) income
(83
)
 
78

Comprehensive income attributable to noncontrolling interests
1

 
4

Comprehensive (loss) income attributable to Delphi Technologies
$
(84
)
 
$
74

See notes to consolidated financial statements.

4

Table of Contents


DELPHI TECHNOLOGIES PLC
CONSOLIDATED BALANCE SHEETS
 
March 31,
2020
 
December 31,
2019
 
(Unaudited)
 
 
 
 
 
 
(in millions)
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
611

 
$
191

Accounts receivable, net
777

 
821

Inventories, net (Note 3)
450

 
447

Other current assets (Note 4)
160

 
189

Total current assets
1,998

 
1,648

Long-term assets:
 
 
 
Property, net
1,478

 
1,509

Investments in affiliates
41

 
42

Intangible assets, net
48

 
53

Goodwill
6

 
7

Deferred income taxes
260

 
269

Other long-term assets (Note 4)
233

 
219

Total long-term assets
2,066

 
2,099

Total assets
$
4,064

 
$
3,747

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Short-term debt (Note 8)
$
49

 
$
40

Accounts payable
672

 
717

Accrued liabilities (Note 5)
475

 
466

Total current liabilities
1,196

 
1,223

Long-term liabilities:
 
 
 
Long-term debt (Note 8)
1,935

 
1,455

Pension and other postretirement benefit obligations (Note 9)
372

 
404

Other long-term liabilities (Note 5)
195

 
210

Total long-term liabilities
2,502

 
2,069

Total liabilities
3,698

 
3,292

Commitments and contingencies (Note 10)


 


Shareholders’ equity:
 
 
 
Preferred shares, $0.01 par value per share, 50,000,000 shares authorized, none issued and outstanding

 

Ordinary shares, $0.01 par value per share, 1,200,000,000 shares authorized, 86,281,713 and 86,071,640 issued and outstanding as of March 31, 2020 and December 31, 2019, respectively
1

 
1

Additional paid-in-capital
411

 
409

Retained earnings
224

 
281

Accumulated other comprehensive loss (Note 14)
(403
)
 
(376
)
Total Delphi Technologies shareholders’ equity
233

 
315

Noncontrolling interest
133

 
140

Total shareholders’ equity
366

 
455

Total liabilities and shareholders’ equity
$
4,064

 
$
3,747

See notes to consolidated financial statements.

5

Table of Contents


DELPHI TECHNOLOGIES PLC
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
Three Months Ended March 31,
 
2020
 
2019
 
 
 
 
 
(in millions)
Cash flows from operating activities:
 
 
 
Net (loss) income
$
(54
)
 
$
19

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation
53

 
47

Amortization
3

 
3

Amortization of deferred debt issuance costs
1

 
1

Impairment of assets
3

 
3

Restructuring expense, net of cash paid
10

 
(6
)
Deferred income taxes
(1
)
 
(3
)
Pension and other postretirement benefit expenses

 
21

Income from equity method investments

 
(2
)
Share-based compensation
4

 
4

Changes in operating assets and liabilities:
 
 
 
Accounts receivable, net
44

 
(36
)
Inventories, net
(3
)
 
(28
)
Other assets
20

 
6

Accounts payable
(14
)
 
(6
)
Accrued and other long-term liabilities
(12
)
 
1

Other, net
(13
)
 
11

Pension contributions
(10
)
 
(14
)
Net cash provided by operating activities
31

 
21

Cash flows from investing activities:
 
 
 
Capital expenditures
(85
)
 
(131
)
Proceeds from sale of property
2

 
2

Dividends from equity method investment
1

 

Cost of technology investments
(1
)
 

Settlement of undesignated derivatives
(1
)
 
(2
)
Net cash used in investing activities
(84
)
 
(131
)
Cash flows from financing activities:
 
 
 
Net repayments under short-term debt agreements
(2
)
 

Repayments under long-term debt agreements
(9
)
 
(9
)
Net borrowings under revolving credit facility
500

 

Dividend payments of consolidated affiliates to minority shareholders
(8
)
 
(8
)
Taxes withheld and paid on employees’ restricted share awards
(1
)
 
(1
)
Repurchase of ordinary shares

 
(14
)
Fees associated with amendments to long-term debt agreements
(3
)
 

Net cash provided by (used in) financing activities
477

 
(32
)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash
(4
)
 

Increase (decrease) in cash, cash equivalents and restricted cash
420

 
(142
)
Cash, cash equivalents and restricted cash at beginning of the period
191

 
360

Cash, cash equivalents and restricted cash at end of the period
$
611

 
$
218

See notes to consolidated financial statements.

6

Table of Contents


DELPHI TECHNOLOGIES PLC
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(Unaudited)

 
Three Months Ended March 31, 2020
 
Ordinary Shares
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of Shares
 
Amount
 
Additional Paid in Capital
 
Retained Earnings
 
Accumulated Other Comprehensive Loss
 
Total Delphi Technologies Shareholders’ Equity
 
Noncontrolling Interest
 
Total Shareholders’ Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
Balance at December 31, 2019
86

 
$
1

 
$
409

 
$
281

 
$
(376
)
 
$
315

 
$
140

 
$
455

Net (loss) income

 

 

 
(57
)
 

 
(57
)
 
3

 
(54
)
Other comprehensive loss

 

 

 

 
(27
)
 
(27
)
 
(2
)
 
(29
)
Dividend payments of consolidated affiliates to minority shareholders

 

 

 

 

 

 
(8
)
 
(8
)
Share-based compensation

 

 
4

 

 

 
4

 

 
4

Taxes withheld on employees’ restricted share award vestings

 

 
(2
)
 

 

 
(2
)
 

 
(2
)
Balance at March 31, 2020
86

 
$
1

 
$
411

 
$
224

 
$
(403
)
 
$
233

 
$
133

 
$
366


 
Three Months Ended March 31, 2019
 
Ordinary Shares
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of Shares
 
Amount
 
Additional Paid in Capital
 
Retained Earnings
 
Accumulated Other Comprehensive Loss
 
Total Delphi Technologies Shareholders’ Equity
 
Noncontrolling Interest
 
Total Shareholders’ Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
Balance at December 31, 2018
89

 
$
1

 
$
407

 
$
296

 
$
(412
)
 
$
292

 
$
146

 
$
438

Net income

 

 

 
16

 

 
16

 
3

 
19

Other comprehensive income

 

 

 

 
58

 
58

 
1

 
59

Dividend payments of consolidated affiliates to minority shareholders

 

 

 

 

 

 
(8
)
 
(8
)
Repurchase of ordinary shares
(1
)
 

 
(4
)
 
(11
)
 

 
(15
)
 

 
(15
)
Share-based compensation

 

 
4

 

 

 
4

 

 
4

Taxes withheld on employees’ restricted share award vestings

 

 
(1
)
 

 

 
(1
)
 

 
(1
)
Balance at March 31, 2019
88

 
$
1

 
$
406

 
$
301

 
$
(354
)
 
$
354

 
$
142

 
$
496

See notes to consolidated financial statements.



7

Table of Contents


DELPHI TECHNOLOGIES PLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
1. GENERAL
On December 4, 2017, Delphi Technologies PLC (“Delphi Technologies,” “we,” “us,” “our” or the “Company”) became an independent publicly-traded company, formed under the laws of Jersey, as a result of the separation of the Powertrain Systems segment, which included the aftermarket operations, from Delphi Automotive PLC (the “Former Parent”). The separation was completed in the form of a pro-rata distribution to the Former Parent shareholders of record on November 22, 2017 of 100% of the outstanding ordinary shares of Delphi Technologies PLC (the “Separation”). Following the Separation, Delphi Automotive PLC changed its name to Aptiv PLC (“Aptiv”). Delphi Technologies’ ordinary shares began trading on the New York Stock Exchange under the ticker symbol “DLPH” on December 5, 2017.
BorgWarner Inc. Transaction
On January 28, 2020, we announced that we had entered into a definitive transaction agreement (the “Original Transaction Agreement”) under which BorgWarner Inc. (“BorgWarner”), a global product leader in clean and efficient technology solutions for combustion, hybrid and electric vehicles, will acquire Delphi Technologies in an all-stock transaction pursuant to a scheme of arrangement (the “Scheme of Arrangement”) under Part 18A of the Companies (Jersey) Law 1991, as amended from time to time (the “Transaction”).
On March 30, 2020, we drew the full available amount under our Revolving Credit Facility (the “Revolver Draw”), resulting in a total of $500 million outstanding under the Revolving Credit Facility. We determined it was prudent and in the best interests of the Company and its shareholders to draw the full $500 million under the facility to protect the business and best position the Company to weather current market conditions and uncertainties caused by the novel coronavirus (“COVID-19”) pandemic.
Following the Revolver Draw, on March 30, 2020, BorgWarner notified the Company of its assertion that the Company materially breached the Original Transaction Agreement as a result of effecting the Revolver Draw without BorgWarner’s prior written consent and also asserted that, if such alleged breach was not cured within 30 days of the Revolver Draw (or April 29, 2020), BorgWarner would have the right to terminate the Original Transaction Agreement. We disputed BorgWarner’s breach assertion on the basis that, among other things, BorgWarner unreasonably withheld and conditioned its consent in material breach of the Original Transaction Agreement.
On May 6, 2020, we resolved our breach dispute with BorgWarner regarding our Revolver Draw by entering into an Amendment and Consent Agreement (the “Amendment” and, together with the Original Transaction Agreement, the “Transaction Agreement”), pursuant to which, among other things, BorgWarner consented to the Revolver Draw and certain other matters, subject to the terms and conditions contained in the Amendment. The Amendment also amends the Original Transaction Agreement to (a) reduce the exchange ratio at which each Delphi Technologies ordinary share will be exchanged from 0.4534 shares of BorgWarner common stock to 0.4307 shares of BorgWarner common stock, and (b) include the following additional conditions to BorgWarner’s obligations to close the Transaction: (i) Delphi Technologies’ net-debt-to-adjusted EBITDA ratio does not exceed (x) 6.5 to 1.0 if closing of the Transaction occurs on or before September 30, 2020, and (y) 7.5 to 1.0 if the closing of the Transaction occurs on or after October 1, 2020, and (ii) as of 11:59 p.m. (New York time) on the date immediately prior to the closing of the Transaction, Delphi Technologies’ outstanding revolver borrowings do not exceed $225 million and, net of cash balances, the revolver borrowings do not exceed $115 million. The Transaction is currently expected to close in the second half of 2020. However, there can be no assurance the conditions to closing will be satisfied or waived or that the Transaction will be completed within the expected time frame or at all. See Item 1A. Risk Factors for risks associated with this Transaction.
Nature of Operations
Delphi Technologies is a leader in the development, design and manufacture of integrated propulsion technologies that enable vehicles to drive cleaner, better and further, by optimizing engine performance, increasing vehicle efficiency, reducing emissions, improving driving performance, and supporting their electrification. The Company is a global supplier to original equipment manufacturers (“OEMs”) seeking to manufacture vehicles that meet and exceed increasingly stringent global regulatory requirements and satisfy consumer demands for an enhanced user experience. We provide advanced fuel injection systems, actuators, valvetrain products, sensors, electronic control modules and power electronics technologies. Additionally, the Company offers a full spectrum of aftermarket products serving a global customer base.
Our comprehensive portfolio of advanced technologies and solutions for all propulsion systems are sold to global OEMs of both light vehicles (passenger cars, trucks, vans and sport-utility vehicles) and commercial vehicles (light-duty, medium-duty and heavy-duty trucks, commercial vans, buses and off-highway vehicles). We also remanufacture and sell our products to leading aftermarket companies, including independent retailers and wholesale distributors. We supply a wide range of aftermarket products and services covering the fuel injection, electronics and engine management, maintenance, and test

8

Table of Contents


equipment and vehicle diagnostics categories. We also add aftermarket know-how in category management, logistics, training, marketing and other dedicated services to provide a full range of aftermarket solutions throughout vehicles’ lifecycle.
Basis of Presentation
The unaudited consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete annual financial statements. These financial statements include all adjustments, which consist of normal recurring items, necessary for a fair presentation. The operating results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year. These financial statements should be read in conjunction with the Delphi Technologies’ Annual Report on Form 10-K for the year ended December 31, 2019.


2. SIGNIFICANT ACCOUNTING POLICIES
There have been no material changes on the Company’s significant accounting policies since the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, except those described below.
Principles of consolidation—The consolidated financial statements as of and for the three months ended March 31, 2020 include the accounts of Delphi Technologies’ subsidiaries in which the Company holds a controlling financial or management interest and variable interest entities of which Delphi Technologies has determined that it is the primary beneficiary. All significant intercompany transactions and balances between consolidated Delphi Technologies businesses have been eliminated.
Delphi Technologies held a $6 million investment in PolyCharge America Inc. (“PolyCharge”) as of December 31, 2019. PolyCharge is a privately-held company that does not have a readily determinable fair value and is measured at cost less impairments, adjusted for observable price changes in orderly transactions for the identical or similar investment of the same issuer. During the three months ended March 31, 2020, Delphi Technologies recorded a $3 million impairment related to its investment in PolyCharge after assessing its ability to recover the carrying amount of the investment.
During the three months ended March 31, 2020, Delphi Technologies made a $1 million investment in Mobilion Ventures L.P. (“Mobilion”), a venture capital fund investing in smart mobility aftermarket companies, over which Delphi Technologies does not exert significant influence.
Use of estimates—Preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect amounts reported therein. Generally, matters subject to estimation and judgment include amounts related to accounts receivable realization, inventory obsolescence, asset impairments, useful lives of intangible and fixed assets, deferred tax asset valuation allowances, income taxes, pension benefit plan assumptions, accruals related to litigation, warranty costs, restructuring, environmental remediation costs, worker’s compensation accruals and healthcare accruals. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from those estimates. Events or changes in circumstances after March 31, 2020, including those resulting from the impacts of the COVID-19 pandemic, will be included in future periods.
Recently adopted accounting pronouncements—In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. This guidance also requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses. The Company adopted this ASU on January 1, 2020. This guidance is applicable to the Company’s accounts receivable allowance for doubtful accounts, reimbursable engineering costs, notes receivable and cash equivalents. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This guidance simplifies how an entity is required to test goodwill for impairment by eliminating step two from the goodwill impairment test, which measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount. Under the new guidance, if a reporting unit’s carrying amount exceeds its fair value, an entity will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The Company adopted this ASU on January 1, 2020. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.
In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. This guidance amends ASC 820 to add, remove and clarify certain

9

Table of Contents


disclosure requirements related to fair value measures. The Company adopted this ASU on January 1, 2020. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.
Recently issued accounting pronouncements not yet adopted—In August 2018, the FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans. This guidance amends ASC 715 to add, remove and clarify certain disclosure requirements related to defined benefit pension and other postretirement plans. The new guidance is effective for fiscal years ending after December 31, 2020. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This guidance provides temporary optional expedients and exceptions for applying US GAAP on contract modifications and hedge accounting affected by reference rate reform if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. The new guidance is effective March 12, 2020 and can be applied through December 31, 2022. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.


3. INVENTORIES, NET
A summary of inventories is shown below:
 
March 31,
2020
 
December 31,
2019
 
 
 
 
 
(in millions)
Productive material
$
211

 
$
210

Work-in-process
44

 
40

Finished goods
195

 
197

Total
$
450

 
$
447




4. ASSETS
Other current assets consisted of the following:
 
March 31,
2020
 
December 31,
2019
 
 
 
 
 
(in millions)
Value added tax receivable
$
86

 
$
107

Prepaid insurance and other expenses
24

 
21

Reimbursable engineering costs
19

 
19

Income and other taxes receivable
9

 
13

Notes receivable
7

 
12

Return assets (Note 11)
7

 
7

Derivative financial instruments (Note 15)
1

 
8

Other
7

 
2

Total
$
160

 
$
189


Other long-term assets consisted of the following:
 
March 31,
2020
 
December 31,
2019
 
 
 
 
 
(in millions)
Operating lease assets
$
101

 
$
107

Income and other taxes receivable
32

 
28

Derivative financial instruments (Note 15)
29

 
13

Investment in Tula Technology, Inc.
21

 
21

Value added tax receivable
4

 
7

Investment in PolyCharge
3

 
6

Debt issuance costs
3

 
2

Reimbursable engineering costs
3

 
1

Other
37

 
34

Total
$
233

 
$
219





10

Table of Contents


5. LIABILITIES
Accrued liabilities consisted of the following:
 
March 31,
2020
 
December 31,
2019
 
 
 
 
 
(in millions)
Restructuring (Note 7)
$
89

 
$
73

Warranty obligations (Note 6)
60

 
63

Income and other taxes payable
56

 
71

Deferred reimbursable engineering
47

 
45

Payroll-related obligations
37

 
48

Accrued rebates
23

 
26

Operating lease liabilities
22

 
22

Accrued interest
18

 
10

Freight
14

 
13

Employee benefits
13

 
5

Outside services
12

 
11

Accrued customer returns
11

 
7

Customer deposits
5

 
6

Dividends to minority shareholders

 
5

Other
68

 
61

Total
$
475

 
$
466


Other long-term liabilities consisted of the following:
 
March 31,
2020
 
December 31,
2019
 
 
 
 
 
(in millions)
Operating lease liabilities
$
86

 
$
93

Accrued income taxes
43

 
45

Warranty obligations (Note 6)
24

 
23

Restructuring (Note 7)
15

 
23

Deferred income taxes
14

 
15

Environmental
2

 
1

Derivative financial instruments (Note 15)
2

 

Other
9

 
10

Total
$
195

 
$
210




6. WARRANTY OBLIGATIONS
Delphi Technologies has recognized its best estimate for its total aggregate warranty reserves, including product recall costs, across its operating segments as of March 31, 2020. The Company estimates the reasonably possible amount to ultimately resolve all matters in excess of the recorded reserves as of March 31, 2020 to be up to approximately $20 million.

11

Table of Contents


The table below summarizes the activity in the product warranty liability for the three months ended March 31, 2020:
 
Warranty Obligations
 
 
 
(in millions)
Accrual balance at December 31, 2019
$
86

Provision for estimated warranties incurred during the period
7

Changes in estimate for pre-existing warranties
5

Settlements made during the period (in cash or in kind)
(12
)
Foreign currency translation and other
(2
)
Accrual balance at March 31, 2020
$
84




7. RESTRUCTURING
The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing Delphi Technologies’ strategy, either in the normal course of business or pursuant to significant restructuring programs.
On October 31, 2019, the Company announced a restructuring plan to reshape and realign the Company’s global technical center footprint and reduce salaried and contract staff, with expected charges of up to $200 million. Certain of these actions are subject to consultation with employee works councils and other employee representatives and are expected to be substantially completed by the end of 2021. The Company recorded pre-tax restructuring charges of $41 million during the three months ended March 31, 2020 related to this plan (approximately $100 million of charges recorded to date). The Company expects to record additional pre-tax restructuring charges of approximately $50 million up to $100 million, across the organization. Nearly all of the restructuring charges will be cash expenditures.
In addition, as part of the Company’s continued efforts to optimize its cost structure, it has undertaken several restructuring programs which include workforce reductions as well as plant closures. These programs are primarily focused on the continued rotation of our manufacturing footprint to best-cost locations in Europe and on reducing global overhead costs. The Company recorded employee-related and other restructuring charges related to these programs totaling approximately $3 million during the three months ended March 31, 2019.
Restructuring charges for employee separation and termination benefits are paid either over the severance period or in a lump sum in accordance with either statutory requirements or individual agreements. Delphi Technologies incurred cash expenditures related to its restructuring programs of approximately $33 million and $9 million in the three months ended March 31, 2020 and 2019, respectively.
The following table summarizes the restructuring charges recorded for the three months ended March 31, 2020 and 2019 by operating segment:
 
Three Months Ended March 31,
 
2020
 
2019
 
 
 
 
 
(in millions)
Fuel Injection Systems
$
32

 
$
3

Powertrain Products
8

 

Electrification & Electronics
1

 

Aftermarket

 

Corporate
2

 

Total
$
43

 
$
3



12

Table of Contents


The table below summarizes the activity in the restructuring liability for the three months ended March 31, 2020:
 
Employee Termination Benefits Liability
 
Other Exit Costs Liability
 
Total
 
 
 
 
 
 
 
(in millions)
Accrual balance at December 31, 2019
$
95

 
$
1

 
$
96

Provision for estimated expenses during the period
43

 

 
43

Payments made during the period
(33
)
 

 
(33
)
Foreign currency and other
(2
)
 

 
(2
)
Accrual balance at March 31, 2020
$
103

 
$
1

 
$
104




8. DEBT
The following is a summary of debt outstanding, net of unamortized issuance costs and discounts, as of March 31, 2020 and December 31, 2019, respectively:
 
March 31, 2020
 
December 31, 2019
 
(in millions)
Term Loan A Facility (net of $3 and $3 unamortized issuance costs)
$
682

 
$
691

Senior Notes at 5.00% (net of $10 and $10 unamortized issuance costs and $2 and $2 discount, respectively)
788

 
788

Revolving Credit Facility
500

 

Finance lease liabilities and other
14

 
16

Total debt
1,984

 
1,495

Less: current portion
(49
)
 
(40
)
Long-term debt
$
1,935

 
$
1,455


Credit Agreement
On September 7, 2017, Delphi Technologies and its wholly-owned subsidiary Delphi Powertrain Corporation entered into a credit agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), with respect to $1.25 billion in senior secured credit facilities, which became effective in conjunction with the Separation. The Credit Agreement consists of a senior secured five-year $750 million term loan facility due December 2022 (the “Term Loan A Facility”) and a $500 million five-year senior secured revolving credit facility (the “Revolving Credit Facility”) (collectively, the “Credit Facilities”) with the lenders party thereto and JPMorgan Chase Bank, N.A. We incurred $9 million of issuance costs in connection with the Credit Agreement. As of March 31, 2020, there was $500 million drawn on the Revolving Credit Facility.
The Credit Facilities are subject to an interest rate, at our option, of either (a) the Administrative Agent’s Alternate Base Rate (“ABR” as defined in the Credit Agreement) or (b) the London Interbank Offered Rate (the “Adjusted LIBOR Rate” as defined in the Credit Agreement) (“LIBOR”), in each case, plus an applicable margin that is based on our corporate credit ratings, as more particularly described below (the “Applicable Rate”). In addition, the Credit Agreement requires payment of additional interest on certain overdue obligations on terms and conditions customary for financings of this type. The interest rate period with respect to LIBOR interest rate options can be set at one-, two-, three-, or six-months as selected by us in accordance with the terms of the Credit Agreement (or other period as may be agreed by the applicable lenders), but payable no less than quarterly. We may elect to change the selected interest rate over the term of the Credit Facilities in accordance with the provisions of the Credit Agreement. The Applicable Rates charged to the Company on the specified date are set forth below:
 
March 31, 2020
 
December 31, 2019
 
LIBOR plus
 
ABR plus
 
LIBOR Plus
 
ABR plus
Revolving Credit Facility
1.525
%
 
0.525
%
 
1.450
%
 
0.450
%
Term Loan A Facility
1.875
%
 
0.875
%
 
1.750
%
 
0.750
%


13

Table of Contents


The Credit Agreement was amended on February 10, 2020. Pursuant to the amendment, the applicable interest rate margins for the Term Loan A Facility will increase or decrease from time to time between 1.50% and 2.25% per annum (for LIBOR loans) and between 0.50% and 1.25% per annum (for ABR loans), in each case based upon changes to our corporate credit ratings. Pursuant to the amendment, the applicable interest rate margins for the Revolving Credit Facility will increase or decrease from time to time between 1.30% and 1.75% per annum (for LIBOR loans) and between 0.30% and 0.75% per annum (for ABR loans), in each case based upon changes to our corporate credit ratings.
In light of current economic conditions and uncertainties arising in connection with the COVID-19 pandemic, the Credit Agreement was further amended on May 4, 2020. Pursuant to the second amendment, the applicable interest rate margins for the Term Loan A Facility will increase or decrease from time to time between 2.00% and 2.75% per annum (for LIBOR loans) and between 1.00% and 1.75% per annum (for ABR loans), in each case based upon changes to our corporate credit ratings. Pursuant to the second amendment, the applicable interest rate margins for the Revolving Credit Facility will increase or decrease from time to time between 1.80% and 2.25% per annum (for LIBOR loans) and between 0.80% and 1.25% per annum (for ABR loans), in each case based upon changes to our corporate credit ratings.
Accordingly, the Applicable Rates for the Credit Facilities will fluctuate during the term of the Credit Agreement based on changes in the ABR, LIBOR or future changes in our corporate credit ratings.
The Credit Agreement contains certain affirmative and negative covenants customary for financings of this type that, among other things, limit our and our subsidiaries’ ability to incur additional indebtedness or liens, to dispose of assets, to make certain fundamental changes, to designate subsidiaries as unrestricted, to make certain investments, to prepay certain indebtedness and to pay dividends, or to make other distributions or redemptions/repurchases, with respect to our and our subsidiaries’ equity interests. In addition, the Credit Agreement requires that we maintain a consolidated net leverage ratio of Consolidated Total Indebtedness to Consolidated Adjusted EBITDA, each as defined in the Credit Agreement (the “Original Ratio”). The Credit Agreement also contains events of default customary for financings of this type, including certain customary change of control events. Pursuant to the Credit Agreement amendment on February 10, 2020, for any fiscal quarter ending on or prior to September 30, 2019 or after December 31, 2020, the Company must maintain a consolidated net leverage ratio of not greater than 3.5 to 1.0 and for any fiscal quarter ending on or after December 31, 2019 and on or prior to December 31, 2020 a consolidated net leverage ratio of not greater than 4.0 to 1.0.
Pursuant to the second Credit Agreement amendment on May 4, 2020, the net leverage ratio definition was amended to be Consolidated Secured Indebtedness to Consolidated Adjusted EBITDA, each as defined in the Credit Agreement (the “Revised Ratio”). For any fiscal quarter ending on or prior to March 31, 2020, the Company must maintain the Revised Ratio of not greater than 4.25 to 1.0 stepping down by 0.5x every quarter starting the quarter ended June 30, 2021, and reverting back to the Original Ratio starting the quarter ended March 31, 2022 to be maintained at a level no greater than 4.0 to 1.0.
The Company was in compliance with the Credit Agreement covenants as of March 31, 2020.
Senior Notes
On September 28, 2017, Delphi Technologies PLC issued $800 million in aggregate principal amount of 5.00% senior unsecured notes due 2025 in a transaction exempt from registration under the Securities Act (the “Senior Notes”).
The Senior Notes indenture contains certain restrictive covenants, including with respect to Delphi Technologies’ (and subsidiaries) ability to incur liens, enter into sale and leaseback transactions and merge with or into other entities. The Company was in compliance with the Senior Notes covenants as of March 31, 2020.
Other Financing
Receivable factoring—The Company is party to a €225 million accounts receivable factoring facility for certain subsidiaries in Europe. As a result of current economic conditions and uncertainties arising in connection with the COVID-19 pandemic, this facility is currently suspended pending negotiation of new terms acceptable to both parties. The facility would be accounted for as short-term debt and borrowings would be subject to the availability of eligible accounts receivable. Collateral is not required related to these trade accounts receivable. This facility matures on November 28, 2022 and will automatically renew on a non-committed, indefinite basis unless terminated by either party. Borrowings bear interest at LIBOR plus a margin for borrowings denominated in British pounds and Euro Interbank Offered Rate ("EURIBOR") plus a margin for borrowings denominated in Euros. The current applicable margin will increase or decrease from time to time between 0.45% and 0.85% based on changes to our corporate credit ratings. There were no amounts outstanding on the European accounts receivable factoring facility as of March 31, 2020 and December 31, 2019.
The Company entered into arrangements with various financial institutions to sell eligible trade receivables from certain Aftermarket customers in North America and Europe. These arrangements can be terminated at any time subject to prior written notice. The receivables under these arrangements are sold to a third party without recourse to the Company and are therefore accounted for as true sales. During the three months ended March 31, 2020 and March 31, 2019, $31 million and

14

Table of Contents


$31 million of receivables were sold under these arrangements, and expenses of $1 million and $1 million were recognized within interest expense, respectively.
In addition, during the three months ended March 31, 2019, one of the Company’s European subsidiaries factored, without recourse, $21 million of receivables related to certain foreign research credits to a financial institution. This transaction was accounted for as a true sale of the receivables, and the Company therefore derecognized this amount from other long-term assets in the consolidated balance sheet as a result of these transactions. During the three months ended March 31, 2019, less than $1 million of expenses were recognized within interest expense related to these transactions.
Finance leases—There were approximately $13 million and $14 million of finance lease obligations outstanding as of March 31, 2020 and December 31, 2019, respectively.
Interest—Cash paid for interest related to debt outstanding, including the effect of interest rate and cross currency swaps, totaled $7 million and $8 million, for the three months ended March 31, 2020 and 2019, respectively.


9. PENSION BENEFITS
The Company sponsors defined benefit pension plans for certain employees and retirees outside of the U.S. Using appropriate actuarial methods and assumptions, the Company’s defined benefit pension plans are accounted for in accordance with FASB ASC Topic 715, Compensation—Retirement Benefits. The Company’s primary non-U.S. plans are located in the United Kingdom (“U.K.”), France and Mexico. The U.K. and certain Mexican plans are funded. In addition, the Company has defined benefit plans in South Korea, Turkey and Italy for which amounts are payable to employees immediately upon separation. The obligations for these plans are recorded over the requisite service period. Delphi Technologies does not have any U.S. pension assets or liabilities.
Effective March 31, 2019, the Company froze future accruals for nearly all U.K. based employees under the related defined benefit plans, replacing them with contributions under defined contribution plans effective April 1, 2019, including additional contributions and other payments to impacted employees over a two-year transition period. As a result of this change, the Company realized a one-time reduction to its pension obligation of $33 million, along with a one-time charge of $15 million in the three months ended March 31, 2019, related to curtailing the defined benefit pension plans in the U.K. For the three months ended March 31, 2020 and 2019, the Company also recognized a charge of $2 million and $7 million, respectively, related to transitional payments to impacted employees. The Company excluded these charges, and expects to exclude related future charges, from our calculation of Adjusted Operating Income.
The amounts shown below reflect the non-U.S. plans’ defined benefit pension (income) expense for the three months ended March 31, 2020 and 2019:
 
Three Months Ended March 31,
 
2020
 
2019
 
 
 
 
 
(in millions)
Service cost
$
2

 
$
7

Interest cost
7

 
9

Expected return on plan assets
(11
)
 
(14
)
Curtailment loss

 
15

Amortization of actuarial losses
2

 
4

Net periodic benefit cost
$

 
$
21


Other postretirement benefit obligations were $1 million and $1 million at March 31, 2020 and December 31, 2019, respectively.


10. COMMITMENTS AND CONTINGENCIES
Ordinary Business Claims
In the normal course of our business, we are named from time to time as a defendant in various legal actions, including arbitrations, class actions, and other litigation. We also from time to time receive subpoenas and other inquiries or requests for information from U.S. and foreign federal, state and local governments on a variety of matters. We accrue for matters when we believe that losses are probable and can be reasonably estimated. Considering, among other things, the legal defenses available

15

Table of Contents


and existing accruals, it is inherently difficult in many matters to determine whether loss is probable or reasonably possible or to estimate the size or range of the possible loss. Accordingly adverse outcomes from such proceedings could exceed the amounts accrued by an amount that could be material to our results of operations or cash flows in any particular reporting period.
We estimate our reasonably possible loss in excess of the amounts accrued for ordinary business claims to be up to $10 million.
Transaction with BorgWarner
Shareholder Litigation
Since the January 28, 2020 announcement that the Company had entered into a definitive transaction agreement with BorgWarner Inc., five complaints have been filed by alleged Company shareholders captioned: Sherman v. Delphi Technologies PLC, et al., Case No. 1:20-cv-00385-UNA (filed in the U.S. District Court for the District of Delaware) (the “Sherman Complaint”); Costa v. Delphi Technologies PLC, et al., Case No. 1:20-cv-02363-PAC, Catalano v. Delphi Technologies, PLC, et al., Case No. 1:20-cv-02520-UA, and Schlageter v. Delphi Technologies PLC, et al., Case No. 1:20-cv-02527-UA (each filed in the U.S. District Court for the Southern District of New York); and Heinowski v. Delphi Technologies PLC, et al., Case No. 2:20-cv-10834-LVP-APP (filed in the U.S. District Court for the Eastern District of Michigan). The complaint in each case names as defendants the Company and the members of the board of directors of the Company and alleges, among other things, that the defendants violated Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 and Rule 14a-9 promulgated thereunder by omitting supposedly material information from the preliminary proxy statement filed by the Company on March 11, 2020, rendering it false and/or misleading. In addition, the Sherman Complaint names BorgWarner as a defendant with respect to its claim under Section 20(a) and, unlike the other complaints, is a putative class action. The plaintiffs in the actions each seek, among other relief, an injunction against proceeding with the shareholder vote on the proposed transaction or consummating the proposed transaction absent corrective disclosures, damages and attorneys’ and expert fees. The Company believes the allegations made in the complaints to be without merit.


11. REVENUE
Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring promised goods or services. The Company generally recognizes revenue when it satisfies a performance obligation by transferring control over a product to a customer. From time to time, we enter into pricing agreements with our customers that provide for price reductions, some of which are conditional upon achieving certain criteria. In these instances, revenue is recognized based on the agreed-upon price at the time of shipment.    
Nature of Goods
The majority of our revenue is recorded at a point in time as defined by ASC Topic 606, Revenue from Contacts with Customers (“ASC 606”) as the customers obtain control of the product upon title transfer and not as the product is manufactured or developed. For certain customers, based on specific terms and conditions pertaining to termination for convenience, Delphi Technologies concluded that it had an enforceable right to payment for performance completed to date and the products have no alternative use to the Company, which requires the recognition of revenue over time as defined by ASC 606. The impact on both revenue and operating income from recognizing revenue over time instead of point in time is not significant.
The amount of revenue recognized for these products is based on the purchase order price and adjusted for revenue allocated to variable consideration (i.e. estimated rebates and price discounts), as applicable. Our payment terms are based on customary business practices and vary by customer type and products offered. The term between invoicing and when payment is due is not significant.
Disaggregation of Revenue
In the following table, net sales to outside customers, based on the manufacturing location, is disaggregated by primary geographical market:
 
Three Months Ended March 31,
 
2020
 
2019
 
(in millions)
North America
$
260

 
$
338

Europe
418

 
542

Asia Pacific
242

 
236

South America
25

 
35

Total
$
945

 
$
1,151


The Fuel Injection Systems, Powertrain Products and Electrification & Electronics segments primarily serve OEMs along with certain Tier 1 suppliers (one that supplies vehicle components directly to manufacturers) and the Aftermarket segment serves sales channels to independent aftermarket customers and original equipment service customers.

16

Table of Contents


In the following table, net sales is disaggregated by customer and sales channels:
 
Three Months Ended March 31,
 
2020
 
2019
 
(in millions)
Sales to OEMs and Tier 1 customers:
 
 
 
Fuel Injection Systems
$
358

 
$
419

Powertrain Products
241

 
302

Electronics & Electrification products
172

 
237

Total sales to OEMs and Tier 1 customers
771

 
958

 
 
 
 
Sales to independent aftermarket customers
121

 
141

Sales to original equipment service customers
53

 
52

Total sales to aftermarket customers
174

 
193

Total
$
945

 
$
1,151


Contract Balances
As discussed above, certain customers have contracts with specific terms and conditions which require recognition of revenue over time as defined by ASC 606. As of March 31, 2020 and December 31, 2019 the recognition of revenue over time resulted in approximately $2 million and $2 million of unbilled accounts receivable, respectively, which are included in accounts receivable, net. There were no other contract assets or liabilities as of March 31, 2020 and December 31, 2019 as defined by ASC 606.
Return Assets
The Aftermarket segment provides certain customers with a right of return. The Company recognizes an estimated return asset (and adjusts for cost of sales) for the right to recover the products returned by the customer. ASC 606 requires that return assets be presented separately from inventory. As of March 31, 2020 and December 31, 2019, the Company had return assets of $7 million and $7 million, respectively, included in other current assets.
Practical Expedients and Exemptions
For our Fuel Injection Systems, Powertrain Products and Electrification & Electronics segments, we define the contract with the customer as the combination of a current purchase order and a current production schedule issued by the customer. For our Aftermarket segment, we define the contract with the customer as the combination of a current purchase order and a master agreement with the customer. Although there are instances where the master agreements may extend beyond one year, there are generally no purchase orders with an expected duration beyond a year.
There are generally no performance obligations outstanding beyond a year. The Company generally does not enter into fixed long-term supply agreements. The Company applies the exemption in ASC 606 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.
In addition, the Company applies the practical expedient in ASC 340 and immediately expenses contract acquisition costs when incurred, including sales commissions, because the amortization period would be one year or less.


12. INCOME TAXES
At the end of each interim period, the Company makes its best estimate of the annual expected effective income tax rate and applies that rate to its ordinary year-to-date earnings or loss. The income tax provision or benefit related to unusual or infrequent items, if applicable, that will be separately reported or reported net of their related tax effects are individually computed and recognized in the interim period in which those items occur. In addition, the effect of changes in enacted tax laws or rates, tax status, judgment on the realizability of a beginning-of-the-year deferred tax asset in future years or income tax contingencies is recognized in the interim period in which the change occurs.
The computation of the annual expected effective income tax rate at each interim period requires certain estimates and assumptions including, but not limited to, the expected pre-tax income (or loss) for the year, projections of the proportion of income (and/or loss) earned and taxed in respective jurisdictions, permanent and temporary differences, and the likelihood of the realizability of deferred tax assets generated in the current year. Jurisdictions with a projected loss for the year or a year-to-date loss for which no tax benefit or expense can be recognized due to a valuation allowance are excluded from the estimated

17

Table of Contents


annual effective tax rate. The impact of such an exclusion could result in a higher or lower effective tax rate during a particular quarter, based upon the composition and timing of actual earnings compared to annual projections. The estimates used to compute the provision or benefit for income taxes may change as new events occur, additional information is obtained or as our tax environment changes. To the extent that the expected annual effective income tax rate changes, the effect of the change on prior interim periods is included in the income tax provision in the period in which the change in estimate occurs.
The Company’s income tax expense and effective tax rate for the three months ended March 31, 2020 and 2019 were as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
 
 
 
 
(dollars in millions)
Income tax expense
$
20

 
$
8

Effective tax rate
(59
)%
 
32
%

The Company’s tax rate is affected by the fact that Delphi Technologies PLC, its parent entity, is a U.K. resident taxpayer, the tax rates in the other jurisdictions in which the Company operates, the relative amount of income earned by jurisdiction and the relative amount of losses or income for which no tax benefit or expense was recognized due to a valuation allowance.
The Company’s effective tax rate for the three months ended March 31, 2020 was impacted by unfavorable changes in geographic income mix in 2020 as compared to 2019 which increased the amount of losses in jurisdictions in which no tax benefit for those losses could be recognized. Primarily driven by the expected impact of the COVID-19 pandemic, the Company has recognized a significantly higher proportion of any such expected geographic full-year 2020 taxable income in the first quarter of 2020 as compared to the first quarter of 2019. The Company’s effective tax rate for the three months ended March 31, 2020 includes net discrete tax benefit of $1 million. The effective tax rate for the three months ended March 31, 2019 was impacted by favorable changes in geographic income mix in 2019 as compared to 2018. The Company’s effective tax rate for the three months ended March 31, 2019 includes net discrete tax benefit of $1 million.
Delphi Technologies PLC is a U.K. resident taxpayer and as such is generally not subject to U.K. tax on remitted foreign earnings.
Cash paid or withheld for income taxes was $10 million and $12 million for the three months ended March 31, 2020 and 2019, respectively.


13. SHAREHOLDERS’ EQUITY AND NET INCOME PER SHARE
Net Income Per Share
Basic net income per share is computed by dividing net income attributable to Delphi Technologies by the weighted average number of ordinary shares outstanding during the period. Diluted net income per share reflects the weighted average dilutive impact of all potentially dilutive securities from the date of issuance and is computed using the treasury stock method by dividing net income attributable to Delphi Technologies by the diluted weighted average number of ordinary shares outstanding. For all periods presented the calculation of net income per share contemplates the dilutive impacts, if any, of the Company’s share-based compensation plans. Refer to Note 18. Share-Based Compensation for additional information.
Weighted Average Shares
The following table illustrates net income per share attributable to Delphi Technologies and the weighted average shares outstanding used in calculating basic and diluted income per share:
 
Three Months Ended March 31,
 
2020
 
2019
 
 
 
 
 
(in millions, except per share data)
Numerator:
 
 
 
Net (loss) income attributable to Delphi Technologies
$
(57
)
 
$
16

Denominator:
 
 
 
Weighted average ordinary shares outstanding, basic
86.17

 
88.45

Dilutive shares related to restricted stock units (“RSUs”)
0.11

 
0.10

Weighted average ordinary shares outstanding, including dilutive shares
86.28

 
88.55

 
 
 
 
Net income per share attributable to Delphi Technologies:
 
 
 
Basic
$
(0.66
)
 
$
0.18

Diluted
$
(0.66
)
 
$
0.18

Anti-dilutive securities share impact

 


Share Repurchases
In January 2019, the Board of Directors elected to suspend the Company’s quarterly dividend and approved a new $200 million share repurchase program, which replaced the previous repurchase authorization from July 2018. Repurchases under this program could be made at management’s discretion from time to time on the open market or through privately negotiated transactions. On October 31, 2019, the Company suspended its share repurchase program.
A summary of the ordinary shares repurchased during the three months ended March 31, 2019 is as follows:
 
Three Months Ended March 31, 2019
Total number of shares repurchased
737,917

Average price paid per share
$
20.33

Total (in millions)
$
15


All repurchased shares were retired and returned to authorized but unissued shares. The repurchased shares are reflected as a reduction of ordinary share capital for the par value of the shares, with the excess applied as reductions to additional paid-in-capital and retained earnings.



18

Table of Contents


14. CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The changes in accumulated other comprehensive income (loss) attributable to Delphi Technologies (net of tax) for the three months ended March 31, 2020 and 2019 are shown below.
 
Three Months Ended March 31,
 
2020
 
2019
 
 
 
 
 
(in millions)
Foreign currency translation adjustments:
 
 
 
Balance at beginning of period
$
(175
)
 
$
(165
)
Aggregate adjustment for the period (1)
(44
)
 
8

Balance at end of period
(219
)
 
(157
)
 
 
 
 
Gains (losses) on derivatives:
 
 
 
Balance at beginning of period
20

 
(2
)
Other comprehensive income before reclassifications (net tax effect of $0 and $0)
6

 
18

Reclassification to income (net tax effect of $0 and $0)
(2
)
 
(2
)
Balance at end of period
24

 
14

 
 
 
 
Pension and postretirement plans:
 
 
 
Balance at beginning of period
(221
)
 
(245
)
Other comprehensive income before reclassifications (net tax effect of $3 and $2)
11

 
19

Reclassification to income (net tax effect $0 and $4)
2

 
15

Balance at end of period
(208
)
 
(211
)
 
 
 
 
Accumulated other comprehensive loss, end of period
$
(403
)
 
$
(354
)
(1)
Includes a gain of $2 million and a loss of $3 million, for the three months ended March 31, 2020 and 2019, respectively, related to the foreign currency impact of intra-entity loans that are of a long-term investment nature. Also included are gains of $3 million and $4 million, for the three months ended March 31, 2020 and 2019, respectively, related to non-derivative net investment hedges. Refer to Note 15. Derivatives and Hedging Activities for further description of these hedges.

19

Table of Contents


Reclassifications from accumulated other comprehensive income (loss) to income for the three months ended March 31, 2020 and 2019 were as follows:
Reclassification Out of Accumulated Other Comprehensive Income (Loss)
Details About Accumulated Other Comprehensive Income (Loss) Components
 
Three Months Ended March 31,
Affected Line Item in the Statement of Operations
 
2020
 
2019
 
 
 
 
 
 
 
 
(in millions)
 
Pension and postretirement plans:
 
 
 
 
 
Actuarial losses
 
$
(2
)
 
$
(4
)
Other income (expense), net (1)
Curtailment
 

 
(15
)
Other income (expense), net (1)
 
 
(2
)
 
(19
)
Income before income taxes
 
 

 
4

Income tax expense
 
 
(2
)
 
(15
)
Net income
 
 

 

Net income attributable to noncontrolling interest
 
 
$
(2
)
 
$
(15
)
Net income attributable to Delphi Technologies
(1)
These accumulated other comprehensive loss components are included in the computation of net periodic pension cost (see Note 9. Pension Benefits for additional details).

Refer to Note. 15 Derivatives and Hedging Activities for additional reclassifications from accumulated other comprehensive income (loss) to income.


15. DERIVATIVES AND HEDGING ACTIVITIES
Cash Flow Hedges
Delphi Technologies is exposed to market risk, such as fluctuations in foreign currency exchange rates, commodity prices and changes in interest rates, which may result in cash flow risks. To manage the volatility relating to these exposures, Delphi Technologies aggregates the exposures on a consolidated basis to take advantage of natural offsets. For exposures that are not offset within its operations, Delphi Technologies enters into various derivative transactions pursuant to its risk management policies, which prohibit holding or issuing derivative financial instruments for speculative purposes, and designation of derivative instruments is performed on a transaction basis to support hedge accounting. The changes in fair value of these hedging instruments are offset in part or in whole by corresponding changes in the fair value or cash flows of the underlying exposures being hedged. Delphi Technologies assesses the initial and ongoing effectiveness of its hedging relationships in accordance with its documented policy.
In December 2018, the Company entered into interest rate swap agreements, designated as cash flow hedges, with a combined notional amount of $400 million where the variable rates under the Term Loan A Facility have been exchanged for a fixed rate. These interest rate swap agreements mature in September 2022 and convert the nature of $400 million of the loan from LIBOR floating-rate debt to fixed-rate debt.

20

Table of Contents


As of March 31, 2020, the Company had the following outstanding notional amounts related to foreign currency forward contracts designated as cash flow hedges that were entered into to hedge forecasted exposures:
Foreign Currency
 
Quantity
Hedged
 
Unit of
Measure
 
Notional Amount
(USD Equivalent)
 
 
(in millions)
Chinese Yuan
 
653

 
RMB
 
$
90

Euro
 
37

 
EUR
 
40

Mexican Peso
 
1,046

 
MXN
 
40

Polish Zloty
 
169

 
PLN
 
40

British Pound
 
21

 
GBP
 
30

Singapore Dollar
 
36

 
SGD
 
30

Turkish Lira
 
62

 
TRY
 
10


As of March 31, 2020, Delphi Technologies has entered into derivative instruments to hedge cash flows extending out to September 2022.
Gains and losses on derivatives qualifying as cash flow hedges are recorded in accumulated other comprehensive income (“OCI”), to the extent that hedges are effective, until the underlying transactions are recognized in earnings. Unrealized amounts in accumulated OCI will fluctuate based on changes in the fair value of hedge derivative contracts at each reporting period. Net losses on cash flow hedges included in accumulated OCI as of March 31, 2020 were approximately $27 million (approximately $27 million, net of tax). Of this total, approximately $12 million of losses are expected to be included in cost of sales and interest expense within the next 12 months and $15 million of losses are expected to be included in cost of sales and interest expense in subsequent periods. Cash flow hedges are discontinued when Delphi Technologies determines it is no longer probable that the originally forecasted transactions will occur. Cash flows from derivatives used to manage foreign exchange and interest rate risks are classified as operating activities within the consolidated statement of cash flows.
Net Investment Hedges
The Company is also exposed to the risk that adverse changes in foreign currency exchange rates could impact its net investment in non-U.S. subsidiaries. To manage this risk, the Company designated a qualifying non-derivative instrument, foreign currency-denominated debt, as a net investment hedge of certain non-U.S. subsidiaries. The gains or losses on instruments designated as net investment hedges are recognized within OCI to offset changes in the value of the net investment in these foreign currency-denominated operations. Gains and losses reported in accumulated other comprehensive income (loss) are reclassified to earnings only when the related currency translation adjustments are required to be reclassified, usually upon sale or liquidation of the investment.
In December 2018 and March 2019, as a means of managing foreign currency risk related to our significant operations in Europe, the Company executed fixed-for-fixed cross currency swaps, in which the Company will pay Euros and receive U.S. dollars with a combined notional amount of $600 million. These agreements are designated as net investment hedges and have a maturity date of September 2022.
Derivatives Not Designated as Hedges
On certain occasions the Company enters into certain foreign currency contracts that are not designated as hedges. When hedge accounting is not applied to derivative contracts, gains and losses are recorded to other income (expense), net and cost of sales in the consolidated statement of operations.

21

Table of Contents


Fair Value of Derivative Instruments in the Balance Sheet
The following table includes the fair value of derivative instruments recorded in the consolidated balance sheets as of March 31, 2020 and December 31, 2019:
 
Asset Derivatives
 
Liability Derivatives
 
Balance Sheet Location*
 
March 31,
2020
 
December 31,
2019
 
Balance Sheet Location*
 
March 31,
2020
 
December 31,
2019
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
Designated as cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency derivatives*
Other current assets
 
$
3

 
$
6

 
Other current assets
 
$
2

 
$

Foreign currency derivatives*
Other long-term assets
 
1

 
2

 
Other long-term assets
 
1

 

Foreign currency derivatives*
Accrued liabilities
 
2

 

 
Accrued liabilities
 
5

 

Foreign currency derivatives*
Other long-term liabilities
 

 

 
Other long-term liabilities
 
2

 

Interest rate swaps*
Other long-term assets
 

 

 
Other long-term assets
 
22

 
11

 
 
 
 
 
 
 
 
 
 
 
 
Designated as net investment hedges:
 
 
 
 
 
 
 
 
 
 
Cross-currency swaps*
Other long-term assets
 
51

 
22

 
Other long-term assets
 

 

Total designated as hedges
 
$
57

 
$
30

 
 
 
$
32

 
$
11

 
 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency derivatives*
Other current assets
 
$
1

 
$
3

 
Other current assets
 
$
1

 
$
1

Foreign currency derivatives*
Accrued liabilities
 
1

 

 
Accrued liabilities
 

 

Total not designated as hedges
 
$
2

 
$
3

 
 
 
$
1

 
$
1

* Derivative instruments are subject to master netting arrangements and are presented on a net basis in the consolidated balance sheets in accordance with accounting guidance related to the offsetting of amounts related to certain contracts.
The fair value of Delphi Technologies’ derivative financial instruments was in a net asset position as of March 31, 2020 and a net asset position as of December 31, 2019.

22

Table of Contents


Effect of Derivatives on the Statement of Operations and Statement of Comprehensive Income
The pre-tax effect of the derivative financial instruments in the consolidated statement of operations and consolidated statement of comprehensive income for the three months ended March 31, 2020 and 2019 is as follows:
Three Months Ended March 31, 2020
Gain (Loss) Recognized in OCI
 
Gain Reclassified from OCI into Income
 
 
 
 
 
(in millions)
Derivatives designated as cash flow hedges:
 
 
 
Foreign currency derivatives
$
(12
)
 
$
3

Interest rate swaps
(11
)
 
(1
)
Derivatives designated as net investment hedges:
 
 
 
Cross-currency swaps
29

 

Total
$
6

 
$
2

 
 
 
 
 
 
 
Loss Recognized in Income
 
 
 
 
 
 
 
(in millions)
Derivatives not designated
 
$
(1
)
Total
 
$
(1
)
 
 
 
 
Three Months Ended March 31, 2019
Gain Recognized in OCI
 
Gain Reclassified from OCI into Income
 
 
 
(in millions)
Derivatives designated as cash flow hedges:
 
 
 
Foreign currency derivatives
$
2

 
$
2

Derivatives designated as net investment hedges:
 
 
 
Cross-currency swaps
16

 
Total
$
18

 
$
2

 
 
 
 
 
 
 
Loss Recognized in Income
 
 
 
 
 
 
 
(in millions)
Derivatives not designated
 
$
(2
)
Total
 
$
(2
)
The gain or loss recognized into income for designated and not designated derivative instruments were recorded to other income, net, interest expense and cost of sales in the consolidated statements of operations for the periods presented above.



23

Table of Contents


16. FAIR VALUE OF FINANCIAL INSTRUMENTS
Fair Value Measurements on a Recurring Basis
Derivative instruments—All derivative instruments are required to be reported on the balance sheet at fair value unless the transactions qualify and are designated as normal purchases or sales. Changes in fair value are reported currently through earnings unless they meet hedge accounting criteria. Delphi Technologies’ derivative exposures are with counterparties with long-term investment grade credit ratings. Delphi Technologies estimates the fair value of its derivative contracts using an income approach based on valuation techniques to convert future amounts to a single, discounted amount. Estimates of the fair value of foreign currency derivative instruments, interest rate swaps and cross-currency swaps are determined using exchange traded prices and rates. Delphi Technologies also considers the risk of non-performance in the estimation of fair value, and includes an adjustment for non-performance risk in the measure of fair value of derivative instruments. The non-performance risk adjustment reflects the credit default spread (“CDS”) applied to the foreign currency exposures by counterparty. When Delphi Technologies is in a net derivative asset position, the counterparty CDS rates are applied to the net derivative asset position. When Delphi Technologies is in a net derivative liability position, estimates of peer companies’ CDS rates are applied to the net derivative liability position.
In certain instances where market data is not available, Delphi Technologies uses management judgment to develop assumptions that are used to determine fair value. This could include situations of market illiquidity for a particular currency or commodity or where observable market data may be limited. In those situations, Delphi Technologies generally surveys investment banks and/or brokers and utilizes the surveyed prices and rates in estimating fair value.
As of March 31, 2020 Delphi Technologies was in a net derivative asset position of $26 million. As of December 31, 2019 Delphi Technologies was in a net derivative asset position of $21 million. No significant adjustments were recorded for nonperformance risk based on the application of peer companies’ CDS rates, evaluation of our own nonperformance risk and because Delphi Technologies’ exposures were to counterparties with investment grade credit ratings. Refer to Note 15. Derivatives and Hedging Activities for further information regarding derivatives.
As of March 31, 2020 and December 31, 2019 Delphi Technologies had the following derivative assets measured at fair value on a recurring basis:
 
Total
 
Quoted Prices in Active Markets
Level 1
 
Significant Other Observable Inputs
Level 2
 
Significant Unobservable Inputs
Level 3
 
 
 
 
 
 
 
 
 
(in millions)
As of March 31, 2020:
 
 
 
 
 
 
 
Foreign currency derivatives*
$
1

 
$

 
$
1

 
$

Interest rate swaps*
(22
)
 

 
(22
)
 

Cross-currency swaps*
51

 

 
51

 

Total
$
30

 
$

 
$
30

 
$

As of December 31, 2019:
 
 
 
 
 
 
 
Foreign currency derivatives*
$
10

 
$

 
$
10

 
$

Interest rate swaps*
(11
)
 

 
(11
)
 

Cross-currency swaps*
22

 

 
22

 

Total
$
21

 
$

 
$
21

 
$

As of March 31, 2020 Delphi Technologies had the following derivative liabilities measured at fair value on a recurring basis (as of December 31, 2019 Delphi Technologies did not have any derivative liabilities):
 
Total
 
Quoted Prices in Active Markets
Level 1
 
Significant Other Observable Inputs
Level 2
 
Significant Unobservable Inputs
Level 3
 
 
 
 
 
 
 
 
 
(in millions)
As of March 31, 2020:
 
Foreign currency derivatives*
$
(4
)
 
$

 
$
(4
)
 
$

Total
$
(4
)
 
$

 
$
(4
)
 
$


* Derivative instruments are subject to master netting arrangements and are presented on a net basis in the consolidated balance sheets in accordance with accounting guidance related to the offsetting of amounts related to certain contracts.

24

Table of Contents


Non-derivative financial instruments—Delphi Technologies’ non-derivative financial instruments include cash and cash equivalents, accounts and notes receivable, accounts payable, as well as debt, which consists of finance lease liabilities, the Senior Notes, the Term Loan A Facility and other debt issued by Delphi Technologies’ non-U.S. subsidiaries. The fair value of debt is based on quoted market prices for instruments with public market data or significant other observable inputs for instruments without a quoted public market price (Level 2). As of March 31, 2020 and December 31, 2019, total debt was recorded at $1,984 million and $1,495 million, respectively, and had estimated fair values of $1,643 million and $1,438 million, respectively. For all other financial instruments recorded at March 31, 2020 and December 31, 2019, fair value approximates book value.
Fair Value Measurements on a Nonrecurring Basis
In addition to items that are measured at fair value on a recurring basis, Delphi Technologies also has items in its balance sheet that are measured at fair value on a nonrecurring basis. As these items are not measured at fair value on a recurring basis, they are not included in the tables above. Nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include certain long-lived assets, equity method investments, other equity investments, intangible assets, asset retirement obligations, share-based compensation and liabilities for exit or disposal activities measured at fair value upon initial recognition. During the three months ended March 31, 2020 and 2019, Delphi Technologies recorded non-cash asset impairment charges totaling $3 million and $3 million, respectively, within other income (expense), net and amortization related to declines in the fair value for certain equity investments and intangible assets, respectively. Fair value of long-lived assets is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved and a review of appraisals. As such, Delphi Technologies has determined that the fair value measurements of long-lived assets fall in Level 3 of the fair value hierarchy.


17. OTHER INCOME (EXPENSE), NET
Other income (expense), net included:
 
Three Months Ended March 31,
 
2020
 
2019
 
 
 
 
 
(in millions)
Interest income
$
2

 
$
2

Components of net periodic benefit cost other than service cost (Note 9)
2

 
(14
)
Impairment of investment in PolyCharge
(3
)
 

Other, net
1

 

Other income (expense), net
$
2

 
$
(12
)



18. SHARE-BASED COMPENSATION
Long Term Incentive Plan
The Delphi Technologies PLC Long-Term Incentive Plan (the “PLC LTIP”) allows for the grant of share-based awards (up to 7,500,000 ordinary shares) for long-term compensation to the employees, directors, consultants and advisors of the Company. The awards can be in the form of shares, options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance awards, and other share-based awards.
Board of Director Awards
On April 26, 2018, Delphi Technologies granted 34,756 RSUs to the Board of Directors at a grant date fair value of approximately $2 million. The RSUs vested on April 24, 2019, and 33,944 ordinary shares, which included shares issued in connection with dividend equivalents, were issued to members of the Board of Directors at a fair value of approximately $1 million.

On April 25, 2019, Delphi Technologies granted 70,924 RSUs to the Board of Directors at a grant date fair value of approximately $2 million. The RSUs vested on April 22, 2020, and 68,018 ordinary shares were issued to members of the Board of Directors at a fair value of less than $1 million.


25

Table of Contents


On April 23, 2020, Delphi Technologies granted 197,902 RSUs to the Board of Directors at a grant date fair value of approximately $2 million. The grant date fair value was determined based on the closing price of the Company’s ordinary shares on April 23, 2020. The RSUs will vest on April 21, 2021.

Executive Awards
The executive awards include a time-based vesting portion and a performance-based vesting portion, as well as continuity awards in certain years. The time-based RSUs vest ratably over three years beginning on the first anniversary of the grant date. The performance-based RSUs vest at the completion of a three-year performance period if certain targets are met. Each executive will receive between 0% and 200% of his or her target performance-based award based on the Company’s performance against established company-wide performance metrics.
The details of the executive grant are as follows:
Grant Date
 
RSUs Granted
 
Grant Date Fair Value
 
Time-Based Award Vesting Dates
 
Performance-Based Award Vesting Date
 
 
(in millions)
 
 
 
 
February 2020
 
1.4
 
$23
 
Annually on the anniversary grant date, 2021-2023
 
December 31, 2022
February 2019
 
1.0
 
$27
 
Annually on the anniversary grant date, 2020-2022
 
December 31, 2021
February 2018
 
0.3
 
$16
 
Annually on the anniversary grant date, 2019-2021
 
December 31, 2020

The grant date fair value of the RSUs is determined based on the target number of awards issued, the closing price of the Company’s ordinary shares on the date of the grant of the award, including an estimate for forfeitures, and a contemporaneous valuation performed by an independent valuation specialist with respect to the relative total shareholder return awards.
A summary of activity, including award grants, vesting and forfeitures for Delphi Technologies employees and non-employee members of the Board of Directors is provided below.
 
RSUs
 
Weighted Average Grant Date Fair Value
 
(in thousands)
 
 
Nonvested, January 1, 2020
1,608

 
$
26.48

Granted
1,374

 
16.89

Vested
(272
)
 
28.39

Forfeited
(99
)
 
29.93

Nonvested, March 31, 2020
2,611

 
21.10


During the three months ended March 31, 2019, the Company entered into an individual one-time award of non-qualified stock options to purchase ordinary shares of the Company, which options had a grant date fair value of $3 million based on a contemporaneous valuation performed by an independent valuation specialist. The options become exercisable in equal parts annually over a 5-year period commencing on the first anniversary of the grant. The options will be exercisable, subject to vesting, for a period of 10 years after the grant date.
Share-based compensation expense recorded within the consolidated statement of operations was $4 million ($4 million, net of tax) and $4 million ($4 million, net of tax) based on the Company’s best estimate of ultimate performance against the respective targets during the three months ended March 31, 2020 and 2019, respectively.
The Company will continue to recognize compensation expense, based on the grant date fair value of the awards applied to the Company’s best estimate of ultimate performance against the respective targets, over the requisite vesting periods of the awards. Based on the grant date fair value of the awards and the Company’s best estimate of ultimate performance against the respective targets as of March 31, 2020, unrecognized compensation expense on a pretax basis of approximately $34 million is anticipated to be recognized over a weighted average period of approximately 2 years.


19. SEGMENT REPORTING
The Company operates its business in the following segments:
Fuel Injection Systems. This segment includes gasoline and diesel fuel injection components and systems. Our gasoline fuel injection portfolio includes a full suite of fuel injection technologies – including pumps, injectors, fuel rail assemblies and complete systems – that deliver greater efficiency for traditional and hybrid vehicles with gasoline combustion

26

Table of Contents


engines. The Company’s Gasoline Direct Injection (“GDi”) technology provides high-precision fuel delivery for optimized combustion, which lowers emissions and improves fuel economy. Our diesel fuel injection systems portfolio provides enhanced engine performance. The Company’s common rail fuel injection system is the core technology for both on and off-highway commercial and light vehicle applications.
Powertrain Products. This segment includes an array of highly-engineered products for traditional combustion and hybrid electric vehicles, including variable valvetrain, smart remote actuators, powertrain sensors, ignition products, canisters, and fuel handling products. These products complement and enhance the efficiency improvements delivered by our fuel injection systems technologies.
Electrification & Electronics. Our electronics portfolio consists of engine and transmission control modules and power electronics. The control modules, containing as much as one million lines of software code, are key components that enable the integration and operation of powertrain products throughout the vehicle. As electrification increases, our proprietary solutions – including supervisory controllers, software, DC/DC converters and inverters – provide better efficiency, reduced weight and lower cost for our OEM customers, while also making these and other components easier to integrate. Manufacturers are also choosing to combine power electronic functionality into one unit, enabling more effective packaging at a lower total cost while increasing Delphi Technologies’ content per vehicle.
Aftermarket. Through this segment we sell products and services to independent aftermarket customers and original equipment service customers. Our aftermarket product portfolio includes a wide range of solutions covering the fuel injection, electronics and engine management, maintenance, and test equipment and vehicle diagnostics categories.
The accounting policies of the segments are the same as those of the consolidated Company, except that the disaggregated financial results for the segments have been prepared using a management approach, which is consistent with the basis and manner in which management internally disaggregates financial information for which Delphi Technologies’ chief operating decision maker regularly reviews financial results to assess performance of, and make internal operating decisions about allocating resources to the segments.
Generally, Delphi Technologies evaluates segment performance based on stand-alone segment net income before interest expense, other income (expense), net, income tax expense, equity income, net of tax, restructuring, separation and transformation costs, asset impairments, pension charges and Transaction related costs (“Adjusted Operating Income”) and accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, at current market prices. Delphi Technologies’ management utilizes Adjusted Operating Income as the key performance measure of segment income or loss to evaluate segment performance, and for planning and forecasting purposes to allocate resources to the segments, as management believes this measure is most reflective of the operational profitability or loss of Delphi Technologies’ operating segments. Consolidated Adjusted Operating Income should not be considered a substitute for results prepared in accordance with U.S. GAAP and should not be considered an alternative to net income attributable to Delphi Technologies, which is the most directly comparable financial measure to Adjusted Operating Income that is prepared in accordance with U.S. GAAP. Adjusted Operating Income, as determined and measured by Delphi Technologies, should also not be compared to similarly titled measures reported by other companies.

27

Table of Contents


Included below are sales and operating data for the Company’s segments for the three months ended March 31, 2020 and 2019.
 
Fuel Injection Systems
 
Powertrain Products
 
Electrification & Electronics
 
Aftermarket
 
Corporate Costs and Other (1)
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
For the Three Months Ended March 31, 2020:
 
 
 
 
 
 
 
 
 
 
Net sales
$
393

 
$
261

 
$
178

 
$
174

 
$
(61
)
 
$
945

Depreciation & amortization
$
30

 
$
11

 
$
13

 
$
1

 
$
1

 
$
56

Adjusted operating income
$
18

 
$
35

 
$
1

 
$
15

 
$
(29
)
 
$
40

Operating income
$
(16
)
 
$
27

 
$
(2
)
 
$
15

 
$
(44
)
 
$
(20
)
Equity income
$

 
$

 
$

 
$

 
$

 
$

Net income attributable to noncontrolling interest
$
1

 
$
2

 
$

 
$

 
$

 
$
3

 
Fuel Injection Systems
 
Powertrain Products
 
Electrification & Electronics
 
Aftermarket
 
Corporate Costs and Other (1)
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
For the Three Months Ended March 31, 2019:
 
 
 
 
 
 
 
 
 
 
Net sales
$
454

 
$
327

 
$
243

 
$
193

 
$
(66
)
 
$
1,151

Depreciation & amortization
$
28

 
$
14

 
$
10

 
$
1

 
$

 
$
53

Adjusted operating income
$
23

 
$
61

 
$
17

 
$
15

 
$
(29
)
 
$
87

Operating income
$
13

 
$
57

 
$
13

 
$
14

 
$
(42
)
 
$
55

Equity income
$
2

 
$

 
$

 
$

 
$

 
$
2

Net income attributable to noncontrolling interest
$

 
$
3

 
$

 
$

 
$

 
$
3

(1)
Corporate Costs and Other includes corporate related expenses not allocated to operating segments, which primarily includes executive administration, corporate finance, legal, human resources, supply chain management and information technology. This column also includes the elimination of inter-segment transactions

28

Table of Contents


The reconciliation of Adjusted Operating Income to Operating Income includes, as applicable, restructuring, separation and transformation costs, asset impairments, pension charges and Transaction related costs. The reconciliation of Adjusted Operating Income to net income attributable to Delphi Technologies for the three and three months ended March 31, 2020 and 2019 are as follows:
 
Fuel Injection Systems
 
Powertrain Products
 
Electrification & Electronics
 
Aftermarket
 
Corporate Costs (1)
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
For the Three Months Ended March 31, 2020:
 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
18

 
$
35

 
$
1

 
$
15

 
$
(29
)
 
$
40

Restructuring
(32
)
 
(8
)
 
(1
)
 

 
(2
)
 
(43
)
Separation and transformation costs (2)

 

 
(2
)
 

 
(1
)
 
(3
)
Transaction related costs (3)

 

 

 

 
(12
)
 
(12
)
Pension charges (4)
(2
)
 

 

 

 

 
(2
)
Operating (loss) income
$
(16
)
 
$
27

 
$
(2
)
 
$
15

 
$
(44
)
 
(20
)
Interest expense
 
 
 
 
 
 
 
 
 
 
(16
)
Other income, net
 
 
 
 
 
 
 
 
 
 
2

Loss before income taxes and equity income
 
 
 
 
 
 
 
 
 
 
(34
)
Income tax expense
 
 
 
 
 
 
 
 
 
 
(20
)
Equity income, net of tax
 
 
 
 
 
 
 
 
 
 

Net loss
 
 
 
 
 
 
 
 
 
 
(54
)
Net income attributable to noncontrolling interest
 
 
 
 
 
 
 
 
 
 
3

Net loss attributable to Delphi Technologies
 
 
 
 
 
 
 
 
 
 
$
(57
)
 
Fuel Injection Systems
 
Powertrain Products
 
Electrification & Electronics
 
Aftermarket
 
Corporate Costs (1)
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
For the Three Months Ended March 31, 2019:
 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
23

 
$
61

 
$
17

 
$
15

 
$
(29
)
 
$
87

Restructuring
(3
)
 

 

 

 

 
(3
)
Separation and transformation costs (2)

 
(1
)
 
(4
)
 

 
(13
)
 
(18
)
Asset impairments

 
(3
)
 

 

 

 
(3
)
Pension charges (4)
(7
)
 

 

 
(1
)
 

 
(8
)
Operating income
$
13

 
$
57

 
$
13

 
$
14

 
$
(42
)
 
55

Interest expense
 
 
 
 
 
 
 
 
 
 
(18
)
Other expense, net
 
 
 
 
 
 
 
 
 
 
(12
)
Income before income taxes and equity income
 
 
 
 
 
 
 
 
 
 
25

Income tax expense
 
 
 
 
 
 
 
 
 
 
(8
)
Equity income, net of tax
 
 
 
 
 
 
 
 
 
 
2

Net income
 
 
 
 
 
 
 
 
 
 
19

Net income attributable to noncontrolling interest
 
 
 
 
 
 
 
 
 
 
3

Net income attributable to Delphi Technologies
 
 
 
 
 
 
 
 
 
 
$
16


(1)
Corporate costs includes corporate related expenses not allocated to operating segments, which primarily includes executive administration, corporate finance, legal, human resources, supply chain management and information technology.

29

Table of Contents


(2)
Separation and transformation costs include one-time incremental expenses associated with becoming a stand-alone publicly-traded company and costs and income associated with the transformation of our global technical center footprint.
(3)
Transaction related costs include charges for due diligence, integration planning and other expenses related to the Transaction with BorgWarner.
(4)
Pension charges include additional contributions to defined contribution plans, other payments to impacted employees and other related expenses resulting from the freeze of future accruals for nearly all U.K. defined benefit pension plans.


20. SUBSEQUENT EVENTS
On May 6, 2020, we resolved our breach dispute with BorgWarner by entering into the Amendment, pursuant to which, among other things, BorgWarner consented to the Revolver Draw and certain other matters, subject to the terms and conditions contained in the Amendment. The Amendment also amends the Original Transaction Agreement to (a) reduce the exchange ratio at which each Delphi Technologies ordinary share will be exchanged from 0.4534 shares of BorgWarner common stock to 0.4307 shares of BorgWarner common stock and (b) include certain additional conditions to BorgWarner’s obligations to close the Transaction requiring that Delphi Technologies’ net-debt-to-adjusted EBITDA ratio and revolving borrowings not exceed certain stated limits. The Transaction is currently expected to close in the second half of 2020. See Note 1. General for additional information.


30


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
Our public communications and U.S. Securities and Exchange Commission filings may contain forward-looking statements. Forward-looking statements often address our current views with respect to our expected future business and financial performance and financial conditions. Forward-looking statements are based on expectations and assumptions that we believe to be reasonable when made, but that may not prove to be accurate. These statements are not guarantees and are subject to risks, uncertainties , changes in circumstances and other factors that are difficult to predict and, which may cause actual results to differ materially and adversely from these forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “potential,” “outlook” or “continue,” the negatives thereof and other comparable terminology. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following:
the severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic and of businesses’ and governments’ responses to the pandemic on our operations and personnel, and on commercial activity and demand across our and our customers’ businesses, and on global supply chains;
uncertainties around the extent to which the COVID-19 pandemic and related impacts will continue to adversely impact our financial condition and results of operations; 
our ability to successfully and cost-effectively restructure our global technical center footprint and reduce salaried and contract staff with minimal disruption to our business;
the international scale and footprint of our operations, which exposes us to a variety of political, economic and regulatory risks, including the risk of changes in government leadership and laws, political instability and economic tensions between governments and changes in international trade policies, new barriers to entry and changes to or withdrawals from free trade agreements, changes in foreign exchange rates and interest rates, and economic downturns in foreign countries, compliance with U.S. and foreign countries’ export controls and economic sanctions;
the cyclical nature of automotive sales and production, pricing pressures and other shifts in the competitive landscape for our products and services or changes in customer preferences and requirements;
price and availability of raw materials used by us and our suppliers;
our ability to maintain contracts that are critical to our operations;
our ability to attract, motivate and retain key executives;
our ability to manage risks associated with a strike, work stoppage or other type of conflict with labor unions and employees or those of its principal customers or suppliers;
the ability of the Company to attract and retain customers and to realize the sales represented by our bookings;
new technologies that displace demand for our products and our ability to develop and commercialize new products to meet our customers’ needs;
the Company’s indebtedness, including the amount thereof and capital availability and cost;
further downgrades of our current short- and long-term credit ratings or rating outlooks, or changes in rating application or methodology, and the related impact on our liquidity, funding profile, costs and competitive position;
the possibility that the proposed Transaction will not be completed;
the cost and outcome of any claims, legal proceedings or investigations, including any potential litigation associated with the proposed Transaction;
the failure or breach of information technology systems; and
severe weather conditions and natural disasters and any resultant disruptions on the supply or production of goods or services or customer demands.
Additional factors are discussed in Part II. Other Information, Item 1A. Risk Factors and under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s filings with the Securities and Exchange Commission, including those set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect the Company. It should be remembered that the price of the ordinary shares and any income from them can go down as well as up. Delphi Technologies disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events and/or otherwise, except as may be required by law.

31


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following management’s discussion and analysis of financial condition and results of operations (“MD&A”) is intended to help you understand the business operations and financial condition of the Company for the three and three months ended March 31, 2020. This discussion should be read in conjunction with Item 1. Financial Statements.
Within this MD&A, “Delphi Technologies,” the “Company,” “we,” “us” and “our” refer to Delphi Technologies PLC and its subsidiaries.
Separation from Delphi Automotive PLC
On December 4, 2017, Delphi Technologies became an independent publicly-traded company as a result of the distribution by Delphi Automotive PLC (the “ Former Parent”) of 100% of the ordinary shares of Delphi Technologies PLC to the Former Parent’s shareholders (the “Separation”). In connection with the Separation, substantially all of the assets and liabilities related to the businesses and operations of the Former Parent’s Powertrain Systems segment were transferred to us or one of our subsidiaries. Assets related to the original equipment service business conducted by the Former Parent’s Powertrain Systems segment prior to the Separation, to the extent related to the sale of products of other segments of the Former Parent to vehicle original equipment manufacturers or their affiliates, were retained by or transferred to the Former Parent or one of its subsidiaries, and all of the Former Parent’s other assets and liabilities were retained by or transferred to the Former Parent or one of its subsidiaries.
As part of the Separation, we entered into a number of agreements with the Former Parent to govern the Separation and our continuing relationship with the Former Parent. These agreements provided for the allocation between Delphi Technologies’ and the Former Parent’s assets, employees, liabilities and obligations attributable to periods prior to, at and after the Separation and govern certain continuing relationships between Delphi Technologies and the Former Parent. Refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 for descriptions of the Separation and Distribution Agreement, Transition Services Agreement, Contract Manufacturing Services Agreements, and Tax Matters Agreement that were entered into in connection with the Separation.
BorgWarner Inc. Transaction
On January 28, 2020, we announced that we had entered into the Original Transaction Agreement under which BorgWarner will acquire us in an all-stock transaction pursuant to the Scheme of Arrangement. On March 30, 2020, we drew the full available amount under our Revolving Credit Facility (the “Revolver Draw”), resulting in a total of $500 million outstanding under the Revolving Credit Facility. We determined it was prudent and in the best interests of the Company and our shareholders to draw the full $500 million under the facility to protect the business and best position the Company to weather current market conditions and uncertainties caused by the COVID-19 pandemic.
Following the Revolver Draw, on March 30, 2020, BorgWarner notified the Company of its assertion that the Company materially breached the Original Transaction Agreement as a result of effecting the Revolver Draw without BorgWarner’s prior written consent and also asserted that, if such alleged breach was not cured within 30 days of the Revolver Draw (or April 29, 2020), BorgWarner would have the right to terminate the Original Transaction Agreement. We disputed BorgWarner’s breach assertion on the basis that, among other things, BorgWarner unreasonably withheld and conditioned its consent in material breach of the Original Transaction Agreement.
On May 6, 2020, we resolved our breach dispute with BorgWarner regarding our Revolver Draw by entering into an Amendment and Consent Agreement (the “Amendment” and, together with the Original Transaction Agreement, the “Transaction Agreement”), pursuant to which, among other things, BorgWarner consented to the Revolver Draw and certain other matters, subject to the terms and conditions contained in the Amendment. The Amendment also amends the Original Transaction Agreement to (a) reduce the exchange ratio at which each Delphi Technologies ordinary share will be exchanged from 0.4534 shares of BorgWarner common stock to 0.4307 shares of BorgWarner common stock, and (b) include the following additional conditions to BorgWarner’s obligations to close the Transaction: (i) Delphi Technologies’ net-debt-to-adjusted EBITDA ratio does not exceed (x) 6.5 to 1.0 if closing of the Transaction occurs on or before September 30, 2020, and (y) 7.5 to 1.0 if the closing of the Transaction occurs on or after October 1, 2020 , and (ii) as of 11:59 p.m. (New York time) on the date immediately prior to the closing of the Transaction, Delphi Technologies’ outstanding revolver borrowings do not exceed $225 million and, net of cash balances, the revolver borrowings do not exceed $115 million. The Transaction is currently expected to close in the second half of 2020. However, there can be no assurance the conditions to closing will be satisfied or waived or that the Transaction will be completed within the expected time frame or at all. See Item 1A. Risk Factors for risks associated with this Transaction.



32

Table of Contents


Executive Overview
Our Business
Delphi Technologies is a global provider of propulsion technologies that make vehicles drive cleaner, better and further. We offer pioneering solutions for internal combustion engine, hybrid and electric passenger cars and commercial vehicles. We build on our original equipment expertise to provide leading service solutions for the aftermarket.
On March 11, 2020, the World Health Organization designated the novel coronavirus (“COVID-19”) outbreak a global pandemic. COVID-19 has negatively affected the global economy, disrupted global supply chains, resulted in significant travel and work restrictions, including temporary closures of the manufacturing facilities of some of our largest OEM customers, and has significantly disrupted global financial markets and automotive production. In response to this global pandemic, the Company has taken measures to protect the health and safety of our employees and conserve cash. We have temporarily closed facilities and implemented work-from-home policies where possible for office-based employees. We have also effected temporary layoffs, moved employees to part-time schedules and implemented pay reductions throughout the organization. We have crisis management teams in place monitoring the rapidly evolving situation and recommending risk mitigation actions as deemed necessary. The outbreak has begun impacting the Company’s results of operations and cash flows. Demand for commercial and passenger vehicle production is being significantly impacted by the disruption of global manufacturing, supply chains, and consumer spending. As this is a developing situation, it is difficult to determine the future impacts of the pandemic. The ultimate magnitude of COVID-19, including the extent of its impact on the Company’s financial and operating results, will be determined by the length of time that the pandemic continues, its effect on the demand for vehicle production, as well as the effect of governmental regulations imposed in response to the pandemic.
As the impact of the COVID-19 pandemic on the economy and the Company’s operations evolves, we continue to evaluate and take actions to preserve adequate liquidity and ensure that our business can continue to operate during these uncertain times. This includes limiting discretionary spending across the organization, re-prioritizing our capital expenditures, executing disciplined inventory management and collecting past due receivables. We also determined it was prudent and in the best interests of the Company and its shareholders to draw down on the full amount of our $500 million Revolving Credit Facility to provide additional liquidity and financial flexibility in light of current economic conditions and uncertainties arising in connection with the COVID-19 pandemic. While significant uncertainty exists as to the full impact of the COVID-19 pandemic, we believe that we have sufficient liquidity to satisfy our cash needs for the foreseeable future. In the event of a sustained market deterioration, however, the Company may need additional liquidity, which would require us to evaluate available alternatives and take appropriate actions.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was signed into law in the United States. The CARES Act provides a substantial stimulus and assistance package intended to address the impact of the COVID-19 pandemic, including tax relief and government loans, grants and investments. The CARES Act did not have a material impact on our consolidated financial statements for the three months ended March 31, 2020. We continue to monitor any effects that may result from the CARES Act.
Our total net sales during the three months ended March 31, 2020 were $945 million, a decrease of 18% compared to the same period of 2019. Volumes declined primarily due to lower global production and the closure of customer production sites related to COVID-19, as well as the continuing decline in passenger car diesel fuel injection systems in Europe.
Our business is directly related to automotive sales and automotive light and commercial vehicle production by our customers. Automotive sales depend on a number of factors, including global and regional economic conditions. Overall global vehicle production decreased by 24% for the three months ended March 31, 2020 and is expected to decline 21% from 2019 levels for the full year 2020. Compared to 2019, vehicle production in 2020 is expected to decrease 16% in China, 24% in Europe, 25% in North America and 28% in South America.
There is also potential that geopolitical factors could adversely impact the U.S. and other economies, and specifically the automotive sector. In particular, changes to international trade agreements or other political pressures could affect the operations of our OEM customers, resulting in reduced automotive production in certain regions or shifts in the mix of production to higher cost regions. Increases in interest rates could also negatively impact automotive production as a result of increased consumer borrowing costs or reduced credit availability. Additionally, economic weakness may result in shifts in the mix of future automotive sales (from vehicles with more content such as luxury vehicles, trucks and sport utility vehicles toward smaller passenger cars) or reductions in industrial production and the corresponding level of freight tonnage being transported. While our diversified customer and geographic revenue base, along with our flexible cost structure, allows us to be positioned to withstand the impact of industry downturns and benefit from industry upturns, shifts in the mix of global automotive production to higher cost regions or to vehicles with less content could adversely impact our profitability.
There have also been periods of increased market volatility and currency exchange rate fluctuations. For instance, the British government has formally initiated the process for withdrawal of the United Kingdom (“U.K.”) from the European Union

33

Table of Contents


(“E.U.”). The withdrawal, which is subject to a transition period due to end on December 31, 2020, has created significant uncertainty about the future relationship between the U.K. and the E.U. These developments, or the perception that any of them could occur, may adversely affect European and worldwide economic and market conditions, significantly reduce global market liquidity and restrict the ability of key market participants to operate in certain financial markets and could contribute to instability in global financial and foreign exchange markets, including increased volatility in interest rates and foreign exchange rates. Although our net exposure to transactions denominated in British pounds is relatively neutral, we are actively monitoring the ongoing potential impacts of these developments and will seek to minimize their impact on our business. For the three months ended March 31, 2020, approximately 15% of our net sales were generated in the U.K., and approximately 15% were denominated in British pounds.
For further detail on the Company’s business strategy and trends, uncertainties and opportunities, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.


Consolidated Results of Operations
Delphi Technologies typically experiences fluctuations in revenue due to changes in OEM production schedules, vehicle sales mix and the net of new and lost business (which we refer to collectively as volume), fluctuations in foreign currency exchange rates (which we refer to as FX), and contractual changes to the sales price (which we refer to as contractual price changes). Changes in sales mix can have either favorable or unfavorable impacts on revenue. Such changes can be the result of shifts in regional growth, shifts in OEM sales demand, as well as shifts in consumer demand related to vehicle segment purchases and content penetration. For instance, a shift in sales demand favoring a particular OEM’s vehicle model for which we do not have a supply contract may negatively impact our revenue. A shift in regional sales demand toward certain markets could favorably impact the sales of those of our customers that have a large market share in those regions, which in turn would be expected to have a favorable impact on our revenue.
We typically experience (as described below) fluctuations in operating income due to:
Volume—changes in volume and changes in mix;
Contractual price changes—adjustments in price;
Operational performance—changes to costs for materials and commodities or manufacturing variances; and
Other—including restructuring costs and any remaining variances not included in Volume, net of contractual price changes or Operational performance.
The automotive component supply industry is traditionally subject to inflationary pressures with respect to raw materials and labor which may place operational and profitability burdens on the entire supply chain. We will continue to work with our customers and suppliers to mitigate the impact of these inflationary pressures in the future. In addition, we expect commodity cost volatility to have a continual impact on future earnings and/or operating cash flows. As such, we continually seek to mitigate both inflationary pressures and our material-related cost exposures using a number of approaches, including combining purchase requirements with customers and/or other suppliers, using alternate suppliers or product designs and negotiating cost reductions and/or commodity cost contract escalation clauses into our vehicle manufacturer supply contracts.

Three Months Ended March 31, 2020 versus Three Months Ended March 31, 2019
The results of operations for the three months ended March 31, 2020 and 2019 were as follows:
 
Three Months Ended March 31,
 
2020
 
2019
 
Favorable/(unfavorable)
 
 
 
 
 
 
 
(dollars in millions)
Net sales
$
945

 
$
1,151

 
$
(206
)
Cost of sales
824

 
983

 
159

Gross margin
121

12.8%
168

14.6%
(47
)
Selling, general and administrative
95

 
104

 
9

Amortization
3

 
6

 
3

Restructuring
43

 
3

 
(40
)
Operating (loss) income
(20
)
 
55

 
(75
)
Interest expense
(16
)
 
(18
)
 
2

Other income (expense), net
2

 
(12
)
 
14

(Loss) income before income taxes and equity income
(34
)
 
25

 
(59
)
Income tax expense
(20
)
 
(8
)
 
(12
)
(Loss) income before equity income
(54
)
 
17

 
(71
)
Equity income, net of tax

 
2

 
(2
)
Net (loss) income
(54
)
 
19

 
(73
)
Net income attributable to noncontrolling interest
3

 
3

 

Net (loss) income attributable to Delphi Technologies
$
(57
)
 
$
16

 
$
(73
)

Total Net Sales
Below is a summary of our total net sales for the three months ended March 31, 2020 versus March 31, 2019.
 
Three Months Ended March 31,
 
 
Variance Due To:
 
2020
 
2019
 
Favorable/(unfavorable)
 
 
Volume
 
Contractual price changes
 
FX
 
Other
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
 
 
(in millions)
Total net sales
$
945

 
$
1,151

 
$
(206
)
 
 
$
(170
)
 
$
(8
)
 
$
(28
)
 
$

 
$
(206
)
Total net sales for the three months ended March 31, 2020 decreased 18% compared to the three months ended March 31, 2019. We experienced decreased volume due to lower global production and the closure of customer production sites related to COVID-19, as well as the continuing decline in passenger car diesel fuel injection systems in Europe. In addition, the unfavorable variance in total net sales was impacted by currency changes, primarily related to the Euro and Chinese Yuan.

Cost of Sales and Gross Margin
Cost of sales is primarily comprised of material, labor, manufacturing overhead, freight, product engineering, design and development expenses, depreciation and amortization, warranty costs and other operating expenses. Gross margin is revenue less cost of sales and gross margin percentage is gross margin as a percentage of net sales.
Cost of sales decreased $159 million for the three months ended March 31, 2020 compared to the three months ended March 31, 2019, as summarized below. The Company’s cost of material was approximately 50% of net sales in both the three months ended March 31, 2020 and 2019.

34

Table of Contents


 
Three Months Ended March 31,
 
 
Variance Due To:
 
2020
 
2019
 
Favorable/(unfavorable)
 
 
Volume
 
Contractual price changes
 
FX
 
Operational performance
 
Other
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(dollars in millions)
 
 
(in millions)
Cost of sales
$
824

 
$
983

 
$
159

 
 
$
81

 
$

 
$
22

 
$
58

 
$
(2
)
 
$
159

Gross margin ($)
$
121

 
$
168

 
$
(47
)
 
 
$
(89
)
 
$
(8
)
 
$
(6
)
 
$
58

 
$
(2
)
 
$
(47
)
Gross margin (%)
12.8
%
 
14.6
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The change in cost of sales primarily reflects the impacts from reduced volume, operational performance improvements and currency exchange. The unfavorable change in gross margin is primarily due to volume including product portfolio and regional mix impacts, partially offset by operational performance improvements. The change related to product portfolio is principally related to a shift in customer demand from higher-margin passenger car diesel fuel systems and an increase in revenues of lower-margin GDi fuel systems.

Selling, General and Administrative Expense
 
Three Months Ended March 31,
 
2020
 
2019
 
Favorable/
(unfavorable)
 
 
 
 
 
 
 
(in millions)
Selling, general and administrative expense
$
95

 
$
104

 
$
9

Selling, general and administrative expense (“SG&A”) includes administrative expenses, information technology costs and incentive compensation related costs. SG&A decreased for the three months ended March 31, 2020 as compared to the three months ended March 31, 2019. This is primarily due to the impact of cost reduction initiatives, including a focus on reducing global overhead costs.

Restructuring
 
Three Months Ended March 31,
 
2020
 
2019
 
Favorable/
(unfavorable)
 
 
 
 
 
 
 
(in millions)
Restructuring
$
43

 
$
3

 
$
(40
)
Restructuring charges during the three months ended March 31, 2020 included $41 million related to the restructuring plan announced on October 31, 2019 to reshape and realign the Company’s global technical center footprint and reduce salaried and contract staff (approximately $100 million of charges recorded to date), with expected charges of up to $200 million. Certain of these actions are subject to consultation with employee works councils and other employee representatives and are expected to be substantially completed by the end of 2021. We expect to record additional pre-tax restructuring charges of approximately $50 million up to $100 million related to this plan, across the organization. Nearly all of the restructuring charges will be cash expenditures.
The charges during the three months ended March 31, 2019 related to programs focused on the continued rotation of our manufacturing footprint and reduction of global overhead costs.
As we operate in a cyclical industry that is impacted by movements in the global and regional economies, we continually evaluate opportunities to further adjust our cost structure and optimize our manufacturing footprint. From time to time, we may incur restructuring expenses to align manufacturing capacity and other costs with prevailing regional automotive production levels and locations, to improve the efficiency and utilization of other locations and in order to increase investment in advanced technologies and engineering.
Refer to Note 7. Restructuring to the unaudited consolidated financial statements included herein for further information regarding restructuring activities.


35

Table of Contents


Other Income (Expense), Net
 
Three Months Ended March 31,
 
2020
 
2019
 
Favorable/
(unfavorable)
 
 
 
 
 
 
 
(in millions)
Other income (expense), net
$
2

 
$
(12
)
 
$
14

The increase in other income for the three months ended March 31, 2020 as compared to the three months ended March 31, 2019 is primarily due to:
A decrease of $16 million in the components of net periodic benefit cost other than service costs related to the Company’s defined benefit pension plans; partially offset by
A $3 million impairment of the Company’s investment in PolyCharge.
Refer to Note 17. Other Income (Expense), net to the unaudited consolidated financial statements included herein for additional information.

Income Taxes
 
Three Months Ended March 31,
 
2020
 
2019
 
Favorable/
(unfavorable)
 
 
 
 
 
 
 
(in millions)
Income tax expense
$
20

 
$
8

 
$
(12
)
The Company’s tax rate is affected by the fact that it is a U.K. resident taxpayer, the tax rates in the U.K. and other jurisdictions in which the Company operates, the relative amount of income earned by jurisdiction and the relative amount of losses or income for which no tax benefit or expense was recognized due to a valuation allowance.
The Company’s effective tax rate was (59)% for the three months ended March 31, 2020. This was impacted by unfavorable changes in geographic income mix in 2020 as compared to 2019 which increased the amount of losses in jurisdictions in which no tax benefit for those losses could be recognized. Primarily driven by the expected impact of the COVID-19 pandemic, the Company has recognized a significantly higher proportion of any such expected geographic full-year 2020 taxable income in the first quarter of 2020 as compared to the first quarter of 2019. The Company’s effective tax rate for the three months ended March 31, 2020 includes net discrete tax benefit of $1 million. The effective tax rate was 32% for three months ended March 31, 2019. This was impacted by unfavorable changes in geographic income mix in 2019 as compared to 2018. The Company’s effective tax rate for the three months ended March 31, 2019 includes net discrete tax expense of $1 million.


Results of Operations by Segment
We operate our core business along the following operating segments, which are grouped on the basis of similar product, market and operating factors:
Fuel Injection Systems. This segment includes gasoline and diesel fuel injection components and systems. Our gasoline fuel injection portfolio includes a full suite of fuel injection technologies – including pumps, injectors, fuel rail assemblies and complete systems – that deliver greater efficiency for traditional and hybrid vehicles with gasoline combustion engines. The Company’s Gasoline Direct Injection (“GDi”) technology provides high-precision fuel delivery for optimized combustion, which lowers emissions and improves fuel economy. Our diesel fuel injection systems portfolio provides enhanced engine performance. The Company’s common rail fuel injection system is the core technology for both on and off-highway commercial and light vehicle applications.
Powertrain Products. This segment includes an array of highly-engineered products for traditional combustion and hybrid electric vehicles, including variable valvetrain, smart remote actuators, powertrain sensors, ignition products, canisters, and fuel handling products. These products complement and enhance the efficiency improvements delivered by our fuel injection systems technologies.
Electrification & Electronics. Our electronics portfolio consists of engine and transmission control modules and power electronics. The control modules, containing as much as one million lines of software code, are key components that enable the integration and operation of powertrain products throughout the vehicle. As electrification increases, our proprietary solutions – including supervisory controllers, software, DC/DC converters and inverters – provide better efficiency, reduced weight and lower cost for our OEM customers, while also making these and other components easier to integrate. Manufacturers are also choosing to combine power electronic functionality into one unit, enabling more effective packaging at a lower total cost while increasing Delphi Technologies’ content per vehicle. These products are expected to experience increased demand as vehicle electrification accelerates.
Aftermarket. Through this segment we sell products and services to independent aftermarket customers and original equipment service customers. Our aftermarket product portfolio includes a wide range of solutions covering the fuel injection, electronics and engine management, maintenance, and test equipment and vehicle diagnostics categories. Our aftermarket business provides a recurring and generally stable revenue base, as replacement of many of these products is non-discretionary in nature.
Our management utilizes Adjusted Operating Income by segment as the key performance measure of segment income or loss and for planning and forecasting purposes, as management believes this measure is most reflective of the operational profitability or loss of our operating segments. Consolidated Adjusted Operating Income should not be considered a substitute for results prepared in accordance with U.S. GAAP and should not be considered an alternative to net income attributable to Delphi Technologies, which is the most directly comparable financial measure to Adjusted Operating Income that is prepared in accordance with U.S. GAAP. Adjusted Operating Income, as determined and measured by Delphi Technologies, should also not be compared to similarly titled measures reported by other companies.

36

Table of Contents


The reconciliations of Adjusted Operating Income to net income attributable to Delphi Technologies for the three months ended March 31, 2020 and 2019 are as follows:
 
Fuel Injection Systems
 
Powertrain Products
 
Electrification & Electronics
 
Aftermarket
 
Corporate Costs (1)
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
For the Three Months Ended March 31, 2020:
 
 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
18

 
$
35

 
$
1

 
$
15

 
$
(29
)
 
$
40

Restructuring
(32
)
 
(8
)
 
(1
)
 

 
(2
)
 
(43
)
Separation and transformation costs (2)

 

 
(2
)
 

 
(1
)
 
(3
)
Transaction related costs (3)

 

 

 

 
(12
)
 
(12
)
Pension charges (4)
(2
)
 

 

 

 

 
(2
)
Operating (loss) income
$
(16
)
 
$
27

 
$
(2
)
 
$
15

 
$
(44
)
 
(20
)
Interest expense
 
 
 
 
 
 
 
 
 
 
(16
)
Other income, net
 
 
 
 
 
 
 
 
 
 
2

Loss before income taxes and equity income
 
 
 
 
 
 
 
 
 
 
(34
)
Income tax expense
 
 
 
 
 
 
 
 
 
 
(20
)
Equity income, net of tax
 
 
 
 
 
 
 
 
 
 

Net loss
 
 
 
 
 
 
 
 
 
 
(54
)
Net income attributable to noncontrolling interest
 
 
 
 
 
 
 
 
 
 
3

Net loss attributable to Delphi Technologies
 
 
 
 
 
 
 
 
 
 
$
(57
)

 
Fuel Injection Systems
 
Powertrain Products
 
Electrification & Electronics
 
Aftermarket
 
Corporate Costs (1)
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
For the Three Months Ended March 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
23

 
$
61

 
$
17

 
$
15

 
$
(29
)
 
$
87

Restructuring
(3
)
 

 

 

 

 
(3
)
Separation and transformation costs (2)

 
(1
)
 
(4
)
 

 
(13
)
 
(18
)
Asset impairments

 
(3
)
 

 

 

 
(3
)
Pension charges (4)
(7
)
 

 

 
(1
)
 

 
(8
)
Operating income
$
13

 
$
57

 
$
13

 
$
14

 
$
(42
)
 
55

Interest expense
 
 
 
 
 
 
 
 
 
 
(18
)
Other expense, net
 
 
 
 
 
 
 
 
 
 
(12
)
Income before income taxes and equity income
 
 
 
 
 
 
 
 
 
 
25

Income tax expense
 
 
 
 
 
 
 
 
 
 
(8
)
Equity income, net of tax
 
 
 
 
 
 
 
 
 
 
2

Net income
 
 
 
 
 
 
 
 
 
 
19

Net income attributable to noncontrolling interest
 
 
 
 
 
 
 
 
 
 
3

Net income attributable to Delphi Technologies
 
 
 
 
 
 
 
 
 
 
$
16


37

Table of Contents


(1)
Corporate Costs includes corporate related expenses not allocated to operating segments, which primarily includes executive administration, corporate finance, legal, human resources, supply chain management and information technology.
(2)
Separation and transformation costs include one-time incremental expenses associated with becoming a stand-alone publicly-traded company and costs and income associated with the transformation of our global technical center footprint.
(3)
Transaction related costs include charges for due diligence, integration planning and other expenses related to the Transaction with BorgWarner.
(4)
Pension charges include additional contributions to defined contribution plans, other payments to impacted employees and other related expenses resulting from the freeze of future accruals for nearly all U.K. defined benefit pension plans.
Net sales, gross margin as a percentage of net sales and Adjusted Operating Income by segment for the three months ended March 31, 2020 and 2019 are as follows:
Net Sales by Segment
 
Three Months Ended March 31,
 
 
Variance Due To:
 
2020
 
2019
 
Favorable/
(unfavorable)
 
 
Volume, net of contractual price changes
 
FX
 
Other
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
 
 
(in millions)
Fuel Injection Systems
$
393

 
$
454

 
$
(61
)
 
 
$
(48
)
 
$
(13
)
 
$

 
$
(61
)
Powertrain Products
261

 
327

 
(66
)
 
 
(61
)
 
(5
)
 

 
(66
)
Electrification & Electronics
178

 
243

 
(65
)
 
 
(61
)
 
(4
)
 

 
(65
)
Aftermarket
174

 
193

 
(19
)
 
 
(13
)
 
(6
)
 

 
(19
)
Eliminations and Other (1)
(61
)
 
(66
)
 
5

 
 
5

 

 

 
5

Total
$
945

 
$
1,151

 
$
(206
)
 
 
$
(178
)
 
$
(28
)
 
$

 
$
(206
)
Gross Margin Percentage by Segment
 
Three Months Ended March 31,
 
2020
 
2019
Fuel Injection Systems
9.4
%
 
9.7
%
Powertrain Products
17.2
%
 
18.7
%
Electrification & Electronics
3.9
%
 
8.2
%
Aftermarket
21.3
%
 
19.7
%
Total
12.8
%
 
14.6
%

Adjusted Operating Income by Segment
 
Three Months Ended March 31,
 
 
Variance Due To:
 
2020
 
2019
 
Favorable/
(unfavorable)
 
 
Volume, net of contractual price changes
 
FX
 
Operational performance
 
Other
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions)
 
 
(in millions)
Fuel Injection Systems
$
18

 
$
23

 
$
(5
)
 
 
$
(39
)
 
$
(3
)
 
$
37

 
$

 
$
(5
)
Powertrain Products
35

 
61

 
(26
)
 
 
(24
)
 

 
4

 
(6
)
 
(26
)
Electrification & Electronics
1

 
17

 
(16
)
 
 
(24
)
 
(1
)
 
7

 
2

 
(16
)
Aftermarket
15

 
15

 

 
 
(9
)
 
2

 
6

 
1

 

Corporate Costs
(29
)
 
(29
)
 

 
 

 
(2
)
 

 
2

 

Total
$
40

 
$
87

 
$
(47
)
 
 
$
(96
)
 
$
(4
)
 
$
54

 
$
(1
)
 
$
(47
)
As noted in the table above, Adjusted Operating Income for the three months ended March 31, 2020 as compared to the three months ended March 31, 2019 was impacted by unfavorable volume and contractual price changes, including product portfolio and regional mix, partially offset by operational performance improvements. The change related to product portfolio is principally related to a shift in customer demand from higher-margin passenger car diesel fuel systems and an increase in revenues of lower-margin GDi fuel systems. Adjusted operating income was also impacted by $3 million of increased depreciation and amortization, included in Other above, which is primarily due to the increased fixed asset base.

38

Table of Contents




Liquidity and Capital Resources
Overview of Capital Structure
The Company’s liquidity requirements are primarily to fund our business operations, including capital expenditures and working capital requirements, operational restructuring activities, separation activities, Transaction activities, to meet debt service requirements, fund our pension obligations and return capital to shareholders. Effective March 31, 2019, the Company froze future accruals for nearly all U.K. based employees under the related defined benefit plans, replacing them with contributions under defined contribution plans effective April 1, 2019, including additional contributions and other payments to impacted employees over a two-year transition period.
Our primary sources of liquidity are cash flows from operations, our existing cash balance, and as necessary, borrowings under available credit facilities and the issuance of long-term debt. To the extent we generate discretionary cash flow we may consider using this additional cash flow for optional prepayments of indebtedness, to undertake new capital investment projects, make acquisitions, to return capital to shareholders and/or for general corporate purposes.
As of March 31, 2020, we had cash and cash equivalents of $611 million, of which $500 million relates to amounts drawn on our Revolving Credit Facility which is held at investment-grade rated banking institutions. During 2017 we entered into the Credit Agreement and completed the offering of the Senior Notes, as defined in Note 8. Debt to the unaudited consolidated financial statements included herein. As of March 31, 2020, we had a total outstanding amount of debt, net of unamortized issuance costs and discounts, of approximately $1,984 million, primarily consisting of $685 million principal outstanding under the $750 million five-year-year term loan pursuant to the Credit Agreement, $800 million principal outstanding under the $800 million senior unsecured notes due 2025 and $500 million related to the Revolving Credit Facility. On March 30, 2020, we determined it was prudent and in the best interests of the Company and its shareholders to draw down on its full $500 million Revolving Credit Facility to provide additional liquidity and financial flexibility in light of current economic conditions and uncertainties arising in connection with the COVID-19 pandemic. As of March 31, 2020, the full available amount was drawn on the Revolving Credit Facility, resulting in $500 million outstanding on the Revolving Credit Facility. Refer to Note 8. Debt to the unaudited consolidated financial statements included herein for additional information.
The Company’s cost of debt under the Credit Agreement is impacted by the corporate credit ratings provided by Standard and Poor’s (“S&P”) and Moody’s, or an equivalent rating agency. Downgrades in the corporate credit rating result in higher interest expense for the Company. In late 2019, S&P and Moody’s downgraded the Company’s corporate credit rating and Fitch revised the Company’s rating outlook to negative from stable. On January 29, 2020, both S&P and Fitch put the Company’s credit ratings on positive watch. In January 2020 and March 2020, Moody’s further downgraded the Company’s Corporate Family Rating to B1 and B2, respectively, while placing the ratings under review for downgrade. 
On October 31, 2019, the Company announced a plan to restructure the Company’s global technical center footprint and reduce salaried and contract staff. The Company expects to record pre-tax restructuring charges of approximately $150 million up to $200 million related to these actions, nearly all of which will be cash expenditures. The Company expects the majority of these cash payments to be paid by the end of 2021. We expect available liquidity to continue to be sufficient to fund our global activities (including restructuring payments, any mandatory payments required under the Credit Agreement as described in Note 8. Debt to the unaudited consolidated financial statements included herein, capital expenditures and funding of potential acquisitions, as applicable).
We also continue to expect to be able to move funds between different countries to manage our global liquidity needs without material adverse tax implications, subject to current monetary policies and to the terms of the Credit Agreement. We utilize a combination of strategies, including dividends, cash pooling arrangements, intercompany loan repayments and other distributions and advances to provide the funds necessary to meet our global liquidity needs. There are no significant restrictions on the ability of our subsidiaries to pay dividends or make other distributions to Delphi Technologies.
Other Financing
Receivable factoring—The Company is party to a €225 million accounts receivable factoring facility for certain subsidiaries in Europe. As a result of current economic conditions and uncertainties arising in connection with the COVID-19 pandemic, this facility is currently suspended pending negotiation of new terms acceptable to both parties. The facility would be accounted for as short-term debt and borrowings would be subject to the availability of eligible accounts receivable. Collateral is not required related to these trade accounts receivable. This facility matures on November 28, 2022 and will automatically renew on a non-committed, indefinite basis unless terminated by either party. Borrowings bear interest at LIBOR plus a margin for borrowings denominated in British pounds and Euro Interbank Offered Rate ("EURIBOR") plus a margin for borrowings denominated in Euros. The current applicable margin will increase or decrease from time to time between 0.45% and 0.85% based on changes to our corporate credit ratings. There were no amounts outstanding on the European accounts receivable factoring facility as

39

Table of Contents


of March 31, 2020 and December 31, 2019. The maximum amount drawn under this facility during the three months ended March 31, 2020 to manage working capital requirements was $17 million.
The Company entered into arrangements with various financial institutions to sell eligible trade receivables from certain Aftermarket customers in North America and Europe. These arrangements can be terminated at any time subject to prior written notice. The receivables under these arrangements are sold to a third party without recourse to the Company and are therefore accounted for as true sales. During the three months ended March 31, 2020 and March 31, 2019, $31 million and $31 million of receivables were sold under these arrangements, and expenses of $1 million and $1 million were recognized within interest expense, respectively.
In addition, during the three months ended March 31, 2019, one of the Company’s European subsidiaries factored, without recourse, $21 million of receivables related to certain foreign research credits to a financial institution. This transaction was accounted for as a true sale of the receivables, and the Company therefore derecognized this amount from other long-term assets in the consolidated balance sheet as a result of these transactions. During the three months ended March 31, 2019, less than $1 million of expenses were recognized within interest expense related to these transactions.
Finance leases—There were approximately $13 million and $14 million of finance lease obligations outstanding as of March 31, 2020 and December 31, 2019, respectively.
Interest—Cash paid for interest related to debt outstanding, including the effect of interest rate and cross currency swaps, totaled $7 million and $8 million, for the three months ended March 31, 2020 and 2019, respectively.
Share Repurchases
In January 2019, the Board of Directors elected to suspend the Company’s quarterly dividend and approved a new $200 million share repurchase program, which replaced the previous repurchase authorization from July 2018. Repurchases under this program could be made at management’s discretion from time to time on the open market or through privately negotiated transactions. On October 31, 2019, the Company suspended its share repurchase program.
A summary of the ordinary shares repurchased during the three months ended March 31, 2019 is as follows:
 
Three Months Ended March 31,
 
2019
Total number of shares repurchased
737,917

Average price paid per share
$
20.33

Total (in millions)
$
15

All repurchased shares were retired and returned to authorized but unissued shares. The repurchased shares are reflected as a reduction of ordinary share capital for the par value of the shares, with the excess applied as reductions to additional paid-in-capital and retained earnings.
Cash Flows
We utilize a combination of strategies, including dividends, cash pooling arrangements, intercompany loan structures and other distributions and advances and may also utilize short-term financing, to provide the funds necessary to meet our global liquidity needs. We utilize a global cash pooling arrangement to consolidate and manage our global cash balances, which enables us to efficiently move cash into and out of a number of the countries in which we operate.
Operating activities—Net cash provided by operating activities totaled $31 million and $21 million for the three months ended March 31, 2020 and 2019, respectively. Cash flow from operating activities for the three months ended March 31, 2020 consisted primarily of a net loss of $54 million increased by $60 million for non-cash charges for depreciation, amortization, asset impairments and pension costs, and by an additional $22 million related to changes in operating assets and liabilities, net of restructuring and pension contributions. Cash flow from operating activities for the three months ended March 31, 2019 consisted primarily of net earnings of $19 million increased by $75 million for non-cash charges for depreciation, amortization, asset impairments and pension costs, partially offset by $72 million related to changes in operating assets and liabilities, net of restructuring and pension contributions.
Investing activities—Net cash used in investing activities totaled $84 million for the three months ended March 31, 2020, as compared to $131 million for the three months ended March 31, 2019. The decrease in usage is primarily attributable to $46 million of decreased capital expenditures during the three months ended March 31, 2020 as compared to the three months ended March 31, 2019.

40

Table of Contents


Financing activities—Net cash provided by financing activities totaled $477 million for the three months ended March 31, 2020 and net cash used in financing activities totaled $32 million for the three months ended March 31, 2019. Cash flows provided by financing activities for the three months ended March 31, 2020 primarily included $500 million of borrowings under the Revolving Credit Facility, partially offset by $9 million of long-term debt repayments and $8 million of dividend payments of consolidated affiliates to minority shareholders. Cash flows used in financing activities for the three months ended March 31, 2019, primarily included $9 million of long-term debt repayments, $14 million paid to repurchase ordinary shares and $8 million of dividend payments of consolidated affiliates to minority shareholders.


Off-Balance Sheet Arrangements
We do not engage in any off-balance sheet financial arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.


Contingencies and Environmental Matters
For a description of contingencies, including environmental contingencies and the amount currently held in reserve for environmental matters, see Note 10. Commitments and Contingencies to the unaudited consolidated financial statements included herein.


Recently Issued Accounting Pronouncements
The information concerning recently issued accounting pronouncements see Note 2. Significant Accounting Policies to the unaudited consolidated financial statements included herein.


Critical Accounting Estimates
There have been no significant changes in our critical accounting estimates during the three months ended March 31, 2020.


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to the information concerning our exposures to market risk as stated in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.


ITEM 4. CONTROLS AND PROCEDURES
A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.
Disclosure Controls and Procedures
Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the U.S. Securities Exchange Act of 1934. The Company maintains disclosure controls and procedures that are designed to provide reasonable assurance of achieving their objectives.
As of March 31, 2020, the Company’s management, with the participation of the Chief Executive Officer and the Chief Financial Officer, has evaluated, for disclosure purposes, the effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective to provide reasonable assurance that the desired control objectives were achieved as of March 31, 2020.
Changes in Internal Control over Financial Reporting
There were no material changes in the Company’s internal controls over financial reporting during the three months ended March 31, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

41

Table of Contents


PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS
We are from time to time subject to various actions, claims, suits, government investigations, and other proceedings incidental to our business, including those arising out of alleged defects, breach of contracts, competition and antitrust matters, product warranties, intellectual property matters, personal injury claims and employment-related matters. For a description of risks related to various legal proceedings and claims, see Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019. For a description of our outstanding material legal proceedings, see Note 10. Commitments and Contingencies to the unaudited consolidated financial statements included herein.

ITEM 1A. RISK FACTORS
The Company is providing these additional risk factors to supplement the risk factors previously described in Part I, “Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.
The COVID-19 pandemic could materially adversely affect our business.
In response to the COVID-19 pandemic, authorities have imposed unprecedented measures, such as travel bans and restrictions, quarantines, shelter-in-place/stay-at-home and social distancing orders, and shutdowns. These measures have significantly reduced global economic activity and caused severe disruption to global labor markets. In particular, the pandemic has disrupted the global automotive industry, specifically customer sales, production volumes and purchases of light vehicles by end-consumers. Global light vehicle production has decreased significantly and many of our largest OEM customers have completely shut down manufacturing operations in some countries and regions, including the United States, Mexico and Europe. As a result, we have modified our production schedules and have experienced, and may continue to experience, delays in the production and distribution of our products and significant loss of sales to our customers. It is difficult to predict the full nature and extent of impacts on demand for our products; however, we are currently seeing negative impacts on demand across our businesses, and are expecting slowing economic conditions to adversely affect results for the remainder of 2020.
The spread of COVID-19 has caused us to modify our business practices (including employee travel, employee work locations, cancellation of physical participation in meetings, events and conferences, and social distancing measures), and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers, partners, vendors, and suppliers. Work-from-home and other measures introduce additional operational risks, including cybersecurity risks, and have affected the way we conduct our product development, validation, qualification, customer support, and other activities, which could have an adverse effect on our operations. There is no certainty that such measures will be sufficient to mitigate the risks posed by the virus, and illness and workforce disruptions could lead to unavailability of key personnel and harm our ability to perform critical functions.
The degree to which COVID-19 impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, and include, but are not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or treat its impact, other actions taken by governments, businesses, and individuals in response to the virus and resulting economic disruption, and how quickly and to what extent normal economic and operating conditions can resume. We are similarly unable to predict the degree to which the pandemic impacts our customers, suppliers, vendors, and other partners, and their financial conditions, but a material effect on these parties could also adversely affect us. When production does resume by us and our customers, volumes may be volatile and we will likely need to modify our production environment to ensure the health and safety of our workers. Restrictions on our access to or operation of our manufacturing facilities, or similar limitations for our vendors and suppliers could impact our ability to meet customer demand and have a material adverse effect on our financial condition and results of operations, particularly if prolonged.
Further adverse changes in economic conditions, including as a result of the pandemic, may also lead to increased credit and collectability risks, higher borrowing costs or reduced availability of capital markets, reduced liquidity, adverse impacts on our suppliers, failures of counterparties including financial institutions and insurers, asset impairments, and declines in the value of our financial instruments.
The impact of COVID-19 can also exacerbate other risks discussed in the Item 1A. Risk Factors section of our 2019 Form 10-K, which could in turn have a material adverse effect on us. Developments related to COVID-19 have been rapidly changing, and additional impacts and risks may arise that we are not aware of or able to appropriately respond to currently.


42

Table of Contents


There can be no assurance that our pending transaction with BorgWarner will be completed on a timely basis or at all.
On January 28, 2020, we announced that we had entered into a definitive transaction agreement (the “Original Transaction Agreement”) under which BorgWarner Inc. (“BorgWarner”), a global product leader in clean and efficient technology solutions for combustion, hybrid and electric vehicles, will acquire Delphi Technologies in an all-stock transaction pursuant to a scheme of arrangement (the “Scheme of Arrangement”) under Part 18A of the Companies (Jersey) Law 1991, as amended from time to time (the “Transaction”). Also as previously disclosed, in response to our draw of approximately $500 million from our revolving credit facility (the “Revolver Draw”) on March 30, 2020, BorgWarner notified us of its assertion that we materially breached the Original Transaction Agreement as a result of effecting the Revolver Draw without BorgWarner’s prior written consent and also asserted that, if such alleged breach was not cured within 30 days of the Revolver Draw, BorgWarner would have the right to terminate the Original Transaction Agreement. We disputed BorgWarner’s breach assertion on the basis that, among other things, BorgWarner unreasonably withheld and conditioned its consent, in material breach of the Original Transaction Agreement. On May 6, 2020, we resolved our breach dispute with BorgWarner by entering into an Amendment and Consent Agreement (the “Amendment” and, together with the Original Transaction Agreement, the “Transaction Agreement”).
Pursuant to the terms of the Transaction Agreement and the Scheme of Arrangement, Delphi Technologies’ shareholders will receive, in exchange for each Delphi Technologies ordinary share, 0.4307 shares of BorgWarner common stock, $0.01 par value per share, and cash in lieu of any fractional share of BorgWarner common stock. Completion of the Transaction is subject to a number of customary closing conditions including, among other things, (i) the receipt of certain governmental clearances, (ii) the absence of legal restraint that prohibits the consummation of the Transaction, (iii) the approval for listing on the NYSE of the new BorgWarner shares issued in connection with the Transaction, (iv) the sanctioning of the Scheme of Arrangement by the Royal Court of Jersey, (v) the receipt of the requisite shareholder vote to approve the Scheme of Arrangement, (vi) the accuracy of each party’s representations and warranties made in the Transaction Agreement, subject to specified materiality standards and (vii) the performance and compliance by each party of all of its obligations and covenants under the Transaction Agreement in all material respects.
In addition, as a result of our entry into the Amendment, the Transaction is subject to the following additional conditions to BorgWarner’s obligations to close the Transaction: (i) Delphi Technologies’ net-debt-to-adjusted EBITDA ratio does not exceed (x) 6.5 to 1.0 if closing of the Transaction occurs on or before September 30, 2020, and (y) 7.5 to 1.0 if the closing of the Transaction occurs on or after October 1, 2020, and (ii) as of 11:59 p.m. (New York time) on the day immediately prior to the closing of the Transaction, Delphi Technologies’ outstanding revolver borrowings do not exceed $225 million and, net of cash balances, the revolver borrowings do not exceed $115 million. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by the full text of the Amendment, a copy of which is attached as Exhibit 2.1 to the Current Report on Form 8-K filed with the SEC on May 6, 2020.
The Transaction is currently expected to close in the second half of 2020. However, there can be no assurance the foregoing conditions to closing will be satisfied or waived or that the Transaction will be completed within the expected time frame or at all.

Delphi Technologies and its shareholders may be negatively impacted if the pending Transaction with BorgWarner is not completed.
If the Transaction is not completed for any reason, including because the conditions to closing are not satisfied, then, among other possible adverse effects:
our shareholders will not receive the consideration contemplated by the Transaction Agreement; 
our share price may decline, to the extent that the current share price reflects a market assumption that the Transaction will be consummated;
our ongoing business may be adversely affected and the attention of our management and employees may be diverted from day-to-day operations;
we may experience difficulties in obtaining financing due to changed perceptions about our competitive position, our management, our liquidity or other aspects of our business;
we may be unable to find a transaction partner willing to engage in a similar transaction on terms as favorable as those set forth in the Transaction Agreement with BorgWarner;
we will remain liable for significant transaction costs and expenses already incurred; and
if the Transaction Agreement is terminated under certain circumstances, we may be obligated to pay a termination fee to BorgWarner of $53.5 million.
The occurrence of any of these events individually or in combination could negatively impact us and our shareholders.


43

Table of Contents


Lawsuits have been filed against us and BorgWarner and other lawsuits may be filed against us and/or BorgWarner challenging the pending Transaction. An adverse ruling in any such lawsuit may delay or prevent the Transaction from being completed.
As of the date of this report, five complaints had been filed by alleged Delphi Technologies shareholders seeking to enjoin the Transaction with BorgWarner: Sherman v. Delphi Technologies PLC, et al., Case No. 1:20-cv-00385-RGA (the “Sherman Complaint”) was filed in the United States District Court for the District of Delaware; Costa v. Delphi Technologies PLC, et al., Case No. 1:20-cv-02363-PAC, Catalano v. Delphi Technologies, PLC et al., Case No. 1:20-cv-02520-UA and Schlageter v. Delphi Technologies PLC, et al., Case No. 1:20-cv-02527-UA were filed in the United States District Court for the Southern District of New York; and Heinowski v. Delphi Technologies PLC, et al., Case No. 2:20-cv-10834-LVP-APP was filed in the United States District Court for the Eastern District of Michigan (collectively, the “Complaints”). Additional complaints arising out of the Transaction may be filed in the future.
The Complaints named as defendants Delphi Technologies and the members of the board of directors and allege, among other things, that the defendants violated Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 and Rule 14a-9 promulgated thereunder by omitting supposedly material information from the preliminary proxy statement filed by Delphi Technologies on March 11, 2020, rendering it false and/or misleading. The Sherman Complaint also names BorgWarner as a defendant with respect to its claim under Section 20(a) and, unlike the other Complaints, is a putative class action. The plaintiffs in the actions each seek, among other relief, an injunction against proceeding with the shareholder vote on the Transaction or consummating the Transaction absent corrective disclosures, damages and attorneys’ and expert fees. While we believe that the allegations made in the Complaints are without merit, there can be no assurance that we will be successful in the outcome of any proceeding related to the Complaints or any other lawsuits that may be brought against us in the future in connection with the Transaction. An adverse ruling in these or similar lawsuits may delay or prevent the Transaction from being completed.  


ITEM 6. EXHIBITS
Exhibit
Number
 
Description
*10.31
 
*10.32
 
*10.33
 
*31.1
 
*31.2
 
*32.1
 
*32.2
 
*101.INS
 
Inline XBRL Instance Document - the instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.
*101.SCH
 
Inline XBRL Taxonomy Extension Schema Document
*101.CAL
 
Inline XBRL Taxonomy Extension Calculation Linkbase Document
*101.DEF
 
Inline XBRL Taxonomy Extension Definition Linkbase Document
*101.LAB
 
Inline XBRL Taxonomy Extension Label Linkbase Document
*101.PRE
 
Inline XBRL Taxonomy Extension Presentation Linkbase Document
*104
 
Cover Page Interactive Data File - the cover page interactive data file does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.
* Filed herewith.

44

Table of Contents


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
 
DELPHI TECHNOLOGIES PLC
 
 
 
 
 
/s/ Vivid Sehgal
 
 
By: Vivid Sehgal
 
 
Chief Financial Officer
 
 
 
Dated: May 7, 2020

45